T0	Noun_Phrase 48 50	A?
T1	IDENTITY_chain 48 50	A?
T2	Noun_Phrase 87 104	Alzheimer Disease
T3	IDENTITY_chain 87 104	Alzheimer Disease
T4	Noun_Phrase 128 141;155 230	The proteases that cleave amyloid-? (A?) peptide from the amyloid precursor protein (APP)
T5	APPOS_relation 128 141;155 230	The proteases that cleave amyloid-? (A?) peptide from the amyloid precursor protein (APP)
T6	IDENTITY_chain 128 141;155 230	The proteases that cleave amyloid-? (A?) peptide from the amyloid precursor protein (APP)
T7	Noun_Phrase 143 153	secretases
T8	Noun_Phrase 167 176	amyloid-?
T9	APPOS_relation 167 176	amyloid-?
T10	Noun_Phrase 167 189	amyloid-? (A?) peptide
T11	IDENTITY_chain 167 189	amyloid-? (A?) peptide
T12	Noun_Phrase 178 180	A?
T13	Noun_Phrase 195 224	the amyloid precursor protein
T14	APPOS_relation 195 224	the amyloid precursor protein
T15	IDENTITY_chain 195 224	the amyloid precursor protein
T16	Noun_Phrase 226 229	APP
T17	Noun_Phrase 318 335	Alzheimer disease
T18	Noun_Phrase 375 377	A?
T19	Noun_Phrase 392 401	the brain
T20	IDENTITY_chain 392 401	the brain
T21	Noun_Phrase 550 557	amyloid
T22	IDENTITY_chain 550 557	amyloid
T23	Noun_Phrase 550 565	amyloid lesions
T24	IDENTITY_chain 550 565	amyloid lesions
T25	Noun_Phrase 603 609	animal
T26	IDENTITY_chain 603 609	animal
T27	Noun_Phrase 620 627	amyloid
T28	Noun_Phrase 620 637	amyloid pathology
T29	IDENTITY_chain 620 637	amyloid pathology
T30	Noun_Phrase 688 695	Methods
T31	IDENTITY_chain 688 695	Methods
T32	Noun_Phrase 710 712	We
T33	IDENTITY_chain 710 712	We
T34	Noun_Phrase 728 854	a transgenic mouse model that genetically mimics the arrest of A? production expected from treatment with secretase inhibitors
T35	IDENTITY_chain 728 854	a transgenic mouse model that genetically mimics the arrest of A? production expected from treatment with secretase inhibitors
T36	Noun_Phrase 741 746	mouse
T37	IDENTITY_chain 741 746	mouse
T38	Noun_Phrase 791 793	A?
T39	Noun_Phrase 834 843	secretase
T40	Noun_Phrase 834 854	secretase inhibitors
T41	IDENTITY_chain 834 854	secretase inhibitors
T42	Noun_Phrase 856 866	These mice
T43	Noun_Phrase 929 940	doxycycline
T44	IDENTITY_chain 929 940	doxycycline
T45	Noun_Phrase 992 995	APP
T46	Noun_Phrase 1022 1029	amyloid
T47	Noun_Phrase 1041 1043	We
T48	Noun_Phrase 1054 1065	doxycycline
T49	Noun_Phrase 1054 1080	doxycycline administration
T50	IDENTITY_chain 1054 1080	doxycycline administration
T51	Noun_Phrase 1090 1104	transgenic APP
T52	IDENTITY_chain 1090 1104	transgenic APP
T53	Noun_Phrase 1090 1115	transgenic APP expression
T54	IDENTITY_chain 1090 1115	transgenic APP expression
T55	Noun_Phrase 1101 1104	APP
T56	Noun_Phrase 1148 1150	A?
T57	Noun_Phrase 1148 1161	A? production
T58	IDENTITY_chain 1148 1161	A? production
T59	Noun_Phrase 1181 1199	nontransgenic mice
T60	IDENTITY_chain 1181 1199	nontransgenic mice
T61	Noun_Phrase 1227 1229	A?
T62	Noun_Phrase 1243 1253	this model
T63	Noun_Phrase 1288 1295	amyloid
T64	Noun_Phrase 1288 1305	amyloid pathology
T65	Noun_Phrase 1348 1355	amyloid
T66	Noun_Phrase 1348 1364	amyloid deposits
T67	IDENTITY_chain 1348 1364	amyloid deposits
T68	Noun_Phrase 1399 1410	the plaques
T69	IDENTITY_chain 1399 1410	the plaques
T70	Noun_Phrase 1474 1477	APP
T71	Noun_Phrase 1546 1548	A?
T72	Noun_Phrase 1580 1587	amyloid
T73	Noun_Phrase 1645 1655	This study
T74	IDENTITY_chain 1645 1655	This study
T75	Noun_Phrase 1674 1681	amyloid
T76	Noun_Phrase 1777 1780	Our
T77	Noun_Phrase 1813 1815	A?
T78	Noun_Phrase 1830 1861	patients with Alzheimer disease
T79	IDENTITY_chain 1830 1861	patients with Alzheimer disease
T80	Noun_Phrase 1844 1861	Alzheimer disease
T81	Noun_Phrase 1893 1902	pathology
T82	Nonreferential_pronoun 1951 1953	it
T83	Noun_Phrase 1967 1974	amyloid
T84	Noun_Phrase 1967 1983	amyloid deposits
T85	Noun_Phrase 2078 2108	the amyloid cascade hypothesis
T86	IDENTITY_chain 2078 2108	the amyloid cascade hypothesis
T87	Noun_Phrase 2082 2089	amyloid
T88	Noun_Phrase 2144 2153	amyloid-?
T89	APPOS_relation 2144 2153	amyloid-?
T90	Noun_Phrase 2144 2166	amyloid-? (A?) peptide
T91	Noun_Phrase 2155 2157	A?
T92	Noun_Phrase 2239 2256	Alzheimer disease
T93	APPOS_relation 2239 2256	Alzheimer disease
T94	Noun_Phrase 2258 2260	AD
T95	Noun_Phrase 2285 2300	this hypothesis
T96	Noun_Phrase 2366 2395	the amyloid precursor protein
T97	APPOS_relation 2366 2395	the amyloid precursor protein
T98	Noun_Phrase 2397 2400	APP
T99	Noun_Phrase 2414 2416	A?
T100	Noun_Phrase 2531 2533	A?
T101	Noun_Phrase 2539 2542	APP
T102	Noun_Phrase 2603 2605	A?
T103	Noun_Phrase 2697 2699	A?
T104	Noun_Phrase 2697 2706	A? levels
T105	IDENTITY_chain 2697 2706	A? levels
T106	Noun_Phrase 2760 2767	peptide
T107	Noun_Phrase 2802 2906	clinical trials of antibody-mediated clearance, one of the first A?-lowering approaches tested in humans
T108	IDENTITY_chain 2802 2906	clinical trials of antibody-mediated clearance, one of the first A?-lowering approaches tested in humans
T109	Noun_Phrase 2821 2848	antibody-mediated clearance
T110	APPOS_relation 2821 2848	antibody-mediated clearance
T111	Noun_Phrase 2850 2906	one of the first A?-lowering approaches tested in humans
T112	Noun_Phrase 2953 2960	amyloid
T113	Noun_Phrase 2953 2967	amyloid burden
T114	IDENTITY_chain 2953 2967	amyloid burden
T115	Noun_Phrase 3003 3013	the trials
T116	Noun_Phrase 3106 3122	several patients
T117	IDENTITY_chain 3106 3122	several patients
T118	Noun_Phrase 3143 3150	amyloid
T119	Noun_Phrase 3143 3160	amyloid pathology
T120	Noun_Phrase 3235 3248	the patient's
T121	Noun_Phrase 3292 3305	this approach
T122	IDENTITY_chain 3292 3305	this approach
T123	Noun_Phrase 3397 3406	the brain
T124	Noun_Phrase 3456 3459	its
T125	Noun_Phrase 3476 3499	An alternative approach
T126	IDENTITY_chain 3476 3499	An alternative approach
T127	Noun_Phrase 3555 3557	AD
T128	Noun_Phrase 3573 3575	A?
T129	Noun_Phrase 3573 3582	A? levels
T130	Noun_Phrase 3595 3598	its
T131	Noun_Phrase 3615 3640	the precursor protein APP
T132	Noun_Phrase 3642 3652	Peptide A?
T133	Noun_Phrase 3670 3673	APP
T134	Noun_Phrase 3691 3702;3757 3829	two enzymes which cleave the holoprotein at the N- and C-termini of A?, respectively
T135	Noun_Phrase 3704 3731	the ?-APP cleaving enzyme 1
T136	APPOS_relation 3704 3755	the ?-APP cleaving enzyme 1 (BACE1) and ?-secretase
T137	Noun_Phrase 3704 3755	the ?-APP cleaving enzyme 1 (BACE1) and ?-secretase
T138	APPOS_relation 3733 3738	BACE1
T139	Noun_Phrase 3733 3738	BACE1
T140	IDENTITY_chain 3733 3738	BACE1
T141	Noun_Phrase 3813 3815	A?
T142	Noun_Phrase 3853 3864	?-secretase
T143	IDENTITY_chain 3853 3864	?-secretase
T144	Noun_Phrase 3932 3955	?-APP cleaving enzyme 1
T145	Noun_Phrase 4050 4056	humans
T146	IDENTITY_chain 4050 4056	humans
T147	Noun_Phrase 4124 4147	?-APP cleaving enzyme 1
T148	Noun_Phrase 4199 4215	transgenic mouse
T149	IDENTITY_chain 4199 4215	transgenic mouse
T150	Noun_Phrase 4199 4229	transgenic mouse models for AD
T151	IDENTITY_chain 4199 4229	transgenic mouse models for AD
T152	Noun_Phrase 4227 4229	AD
T153	Nonreferential_pronoun 4286 4288	it
T154	Noun_Phrase 4310 4319	the brain
T155	Noun_Phrase 4343 4350	amyloid
T156	Noun_Phrase 4365 4381	production of A?
T157	Noun_Phrase 4379 4381	A?
T158	Noun_Phrase 4413 4442	the amyloid-lowering approach
T159	Noun_Phrase 4476 4482	animal
T160	Noun_Phrase 4526 4534	patients
T161	Noun_Phrase 4558 4567	secretase
T162	Noun_Phrase 4650 4652	we
T163	Noun_Phrase 4665 4670	mouse
T164	Noun_Phrase 4733 4736	APP
T165	Noun_Phrase 4748 4759	This system
T166	IDENTITY_chain 4748 4759	This system
T167	Noun_Phrase 4867 4872	water
T168	IDENTITY_chain 4867 4872	water
T169	Noun_Phrase 4882 4944	The strong expression levels produced with the tet-off vectors
T170	IDENTITY_chain 4882 4944	The strong expression levels produced with the tet-off vectors
T171	Noun_Phrase 4929 4936	tet-off
T172	IDENTITY_chain 4929 4936	tet-off
T173	Noun_Phrase 4982 4997	this expression
T174	Noun_Phrase 5034 5046	tetracycline
T175	IDENTITY_chain 5034 5046	tetracycline
T176	Noun_Phrase 5136 5138	A?
T177	Noun_Phrase 5136 5149	A? production
T178	Noun_Phrase 5182 5189	amyloid
T179	Noun_Phrase 5182 5199	amyloid pathology
T180	Noun_Phrase 5224 5237	these lesions
T181	Noun_Phrase 5283 5290	Methods
T182	Noun_Phrase 5292 5301	Transgene
T183	IDENTITY_chain 5292 5301	Transgene
T184	Noun_Phrase 5316 5318	We
T185	Noun_Phrase 5327 5412	a tetracycline-responsive chimeric mouse/human APP695Swedish/Indiana (swe/ind) vector
T186	IDENTITY_chain 5327 5412	a tetracycline-responsive chimeric mouse/human APP695Swedish/Indiana (swe/ind) vector
T187	Noun_Phrase 5329 5395	tetracycline-responsive chimeric mouse/human APP695Swedish/Indiana
T188	APPOS_relation 5329 5395	tetracycline-responsive chimeric mouse/human APP695Swedish/Indiana
T189	Noun_Phrase 5397 5404	swe/ind
T190	Noun_Phrase 5430 5438	promoter
T191	IDENTITY_chain 5430 5438	promoter
T192	Noun_Phrase 5513 5563	the tetracycline-responsive promoter of pTetSplice
T193	IDENTITY_chain 5513 5563	the tetracycline-responsive promoter of pTetSplice
T194	Noun_Phrase 5553 5563	pTetSplice
T195	IDENTITY_chain 5553 5563	pTetSplice
T196	Noun_Phrase 5639 5675	mouse APP with a humanized A? domain
T197	APPOS_relation 5639 5675	mouse APP with a humanized A? domain
T198	IDENTITY_chain 5639 5675	mouse APP with a humanized A? domain
T199	Noun_Phrase 5639 5694	mouse APP with a humanized A? domain (mo/huAPP695) cDNA
T200	IDENTITY_chain 5639 5694	mouse APP with a humanized A? domain (mo/huAPP695) cDNA
T201	Noun_Phrase 5677 5688	mo/huAPP695
T202	Noun_Phrase 5700 5714	the new vector
T203	Noun_Phrase 5716 5718	We
T204	Noun_Phrase 5736 5799	the tetracycline-responsive promoter (bp 6–481) from pTetSplice
T205	Noun_Phrase 5789 5799	pTetSplice
T206	Noun_Phrase 5841 5846	BamHI
T207	IDENTITY_chain 5841 5846	BamHI
T208	Noun_Phrase 5851 5855	NotI
T209	IDENTITY_chain 5851 5855	NotI
T210	Noun_Phrase 5882 5887	BamHI
T211	Noun_Phrase 5925 5929	XhoI
T212	IDENTITY_chain 5925 5929	XhoI
T213	Noun_Phrase 5934 5939	BamHI
T214	Noun_Phrase 5953 5965	the promoter
T215	Noun_Phrase 6086 6088	We
T216	Noun_Phrase 6107 6117	moPrP.XhoI
T217	IDENTITY_chain 6107 6117	moPrP.XhoI
T218	Noun_Phrase 6178 6183	BamHI
T219	Noun_Phrase 6233 6239	Asp718
T220	IDENTITY_chain 6233 6239	Asp718
T221	Noun_Phrase 6248 6254	exon 2
T222	IDENTITY_chain 6248 6254	exon 2
T223	Noun_Phrase 6415 6462	Invitrogen, Carlsbad, California, United States
T224	IDENTITY_chain 6415 6462	Invitrogen, Carlsbad, California, United States
T225	Noun_Phrase 6481 6487	Asp718
T226	Noun_Phrase 6524 6530	Asp718
T227	Noun_Phrase 6543 6553	moPrP.XhoI
T228	Noun_Phrase 6565 6571	exon 2
T229	Noun_Phrase 6597 6608	pBluescript
T230	IDENTITY_chain 6597 6608	pBluescript
T231	Noun_Phrase 6621 6685	an intermediate vector with all three exons and a central intron
T232	IDENTITY_chain 6621 6685	an intermediate vector with all three exons and a central intron
T233	Noun_Phrase 6703 6714	This vector
T234	Noun_Phrase 6738 6743	BamHI
T235	Noun_Phrase 6907 6948	the tetracycline promoter from pTetSplice
T236	Noun_Phrase 6911 6923	tetracycline
T237	Noun_Phrase 7008 7018	moPrP.XhoI
T238	Noun_Phrase 7046 7057	pBluescript
T239	Noun_Phrase 7075 7077	We
T240	Noun_Phrase 7091 7094;7121 7128;7137 7146	the Indiana mutations
T241	APPOS_relation 7091 7094;7121 7128;7137 7146	the Indiana mutations
T242	IDENTITY_chain 7091 7094;7121 7128;7137 7146	the Indiana mutations
T243	Noun_Phrase 7091 7102;7137 7146	the Swedish mutations
T244	APPOS_relation 7091 7102;7137 7146	the Swedish mutations
T245	IDENTITY_chain 7091 7102;7137 7146	the Swedish mutations
T246	Noun_Phrase 7104 7115	KM570/571NL
T247	Noun_Phrase 7130 7135	V617F
T248	Noun_Phrase 7152 7172	the mo/huAPP695 cDNA
T249	Noun_Phrase 7156 7167	mo/huAPP695
T250	Noun_Phrase 7228 7262	two partially overlapping products
T251	IDENTITY_chain 7228 7262	two partially overlapping products
T252	Noun_Phrase 7525 7545	The two PCR products
T253	Noun_Phrase 7533 7536	PCR
T254	IDENTITY_chain 7533 7536	PCR
T255	Noun_Phrase 7703 7707	XhoI
T256	Noun_Phrase 7812 7820	Founders
T257	IDENTITY_chain 7812 7820	Founders
T258	Noun_Phrase 7916 7927	pBluescript
T259	Noun_Phrase 7961 7965	NotI
T260	Noun_Phrase 8073 8088	Founder animals
T261	Noun_Phrase 8123 8136	the transgene
T262	Noun_Phrase 8270 8301	the tetracycline transactivator
T263	APPOS_relation 8270 8301	the tetracycline transactivator
T264	Noun_Phrase 8270 8410	the tetracycline transactivator (tTA) under control of the calcium-calmodulin kinase II? (CaMKII?) promoter obtained from Jackson Laboratory
T265	IDENTITY_chain 8270 8410	the tetracycline transactivator (tTA) under control of the calcium-calmodulin kinase II? (CaMKII?) promoter obtained from Jackson Laboratory
T266	Noun_Phrase 8303 8306	tTA
T267	Noun_Phrase 8325 8410	the calcium-calmodulin kinase II? (CaMKII?) promoter obtained from Jackson Laboratory
T268	IDENTITY_chain 8325 8410	the calcium-calmodulin kinase II? (CaMKII?) promoter obtained from Jackson Laboratory
T269	Noun_Phrase 8329 8358	calcium-calmodulin kinase II?
T270	APPOS_relation 8329 8358	calcium-calmodulin kinase II?
T271	IDENTITY_chain 8329 8358	calcium-calmodulin kinase II?
T272	Noun_Phrase 8360 8367	CaMKII?
T273	Noun_Phrase 8392 8410	Jackson Laboratory
T274	IDENTITY_chain 8392 8410	Jackson Laboratory
T275	Noun_Phrase 8551 8561;8570 8573	transgenic APP
T276	Noun_Phrase 8605 8608	APP
T277	Noun_Phrase 8672 8678	Animal
T278	Noun_Phrase 8830 8841	Doxycycline
T279	Noun_Phrase 8830 8856	Doxycycline Administration
T280	Noun_Phrase 8858 8869	Doxycycline
T281	APPOS_relation 8858 8869	Doxycycline
T282	Noun_Phrase 8871 8874	dox
T283	Noun_Phrase 8901 8943	commercially available dox-containing chow
T284	IDENTITY_chain 8901 8943	commercially available dox-containing chow
T285	Noun_Phrase 8994 9002	The chow
T286	Noun_Phrase 9026 9036	antibiotic
T287	Noun_Phrase 9080 9085	mouse
T288	Noun_Phrase 9137 9140	dox
T289	Noun_Phrase 9202 9205	dox
T290	Noun_Phrase 9236 9240	Chow
T291	Noun_Phrase 9296 9310	the antibiotic
T292	Noun_Phrase 9388 9391	PCR
T293	Noun_Phrase 9388 9454	PCR amplification of genomic DNA extracted from a 5-mm tail biopsy
T294	IDENTITY_chain 9388 9454	PCR amplification of genomic DNA extracted from a 5-mm tail biopsy
T295	Noun_Phrase 9648 9659	supernatant
T296	IDENTITY_chain 9648 9659	supernatant
T297	Noun_Phrase 9673 9686	amplification
T298	IDENTITY_chain 9673 9686	amplification
T299	Noun_Phrase 9704 9707	APP
T300	Noun_Phrase 9704 9707;9716 9726	APP transgenes
T301	IDENTITY_chain 9704 9707;9716 9726	APP transgenes
T302	Noun_Phrase 9704 9726	APP and tTA transgenes
T303	IDENTITY_chain 9704 9726	APP and tTA transgenes
T304	Noun_Phrase 9712 9715	tTA
T305	IDENTITY_chain 9712 9715	tTA
T306	Noun_Phrase 9712 9726	tTA transgenes
T307	IDENTITY_chain 9712 9726	tTA transgenes
T308	Noun_Phrase 9744 9765	the same PCR reaction
T309	Noun_Phrase 9753 9756	PCR
T310	Noun_Phrase 9796 9799	APP
T311	Noun_Phrase 9868 9871	APP
T312	Noun_Phrase 10013 10030	The tTA transgene
T313	Noun_Phrase 10017 10020	tTA
T314	Noun_Phrase 10085 10088	its
T315	Noun_Phrase 10109 10112	tet
T316	IDENTITY_chain 10109 10112	tet
T317	Noun_Phrase 10145 10157	tetracycline
T318	Noun_Phrase 10205 10208	tet
T319	Noun_Phrase 10363 10370	protein
T320	IDENTITY_chain 10363 10370	protein
T321	Noun_Phrase 10411 10427	a forward primer
T322	APPOS_relation 10429 10436	PrP-S-J
T323	Noun_Phrase 10429 10436	PrP-S-J
T324	Noun_Phrase 10454 10459	mouse
T325	Noun_Phrase 10520 10536	a reverse primer
T326	APPOS_relation 10538 10546	PrP-AS-J
T327	Noun_Phrase 10538 10546	PrP-AS-J
T328	Noun_Phrase 10572 10595	the endogenous PrP gene
T329	IDENTITY_chain 10572 10595	the endogenous PrP gene
T330	Noun_Phrase 10604 10613	transgene
T331	Noun_Phrase 10622 10635	Amplification
T332	Noun_Phrase 10792 10815	the endogenous PrP gene
T333	Noun_Phrase 10817 10834	The APP transgene
T334	Noun_Phrase 10821 10824	APP
T335	Noun_Phrase 10877 10880	tTA
T336	Noun_Phrase 10917 10931	Immunoblotting
T337	IDENTITY_chain 10917 10931	Immunoblotting
T338	Noun_Phrase 10971 10980	forebrain
T339	IDENTITY_chain 10971 10980	forebrain
T340	Noun_Phrase 11037 11062	phosphate-buffered saline
T341	APPOS_relation 11037 11062	phosphate-buffered saline
T342	Noun_Phrase 11064 11067	PBS
T343	Noun_Phrase 11134 11175	Sigma, St. Louis, Missouri, United States
T344	IDENTITY_chain 11134 11175	Sigma, St. Louis, Missouri, United States
T345	Noun_Phrase 11372 11387	the supernatant
T346	Noun_Phrase 11397 11405	analysis
T347	IDENTITY_chain 11397 11405	analysis
T348	Noun_Phrase 11425 11429	6E10
T349	IDENTITY_chain 11425 11429	6E10
T350	Noun_Phrase 11434 11438	CT15
T351	IDENTITY_chain 11434 11438	CT15
T352	Noun_Phrase 11449 11454	22C11
T353	IDENTITY_chain 11449 11454	22C11
T354	Noun_Phrase 11459 11464	brain
T355	Noun_Phrase 11546 11603	Bio-Rad Laboratories, Hercules, California, United States
T356	IDENTITY_chain 11546 11603	Bio-Rad Laboratories, Hercules, California, United States
T357	Noun_Phrase 11646 11684	1× Tris-glycine–sodium dodecyl sulfate
T358	APPOS_relation 11646 11684	1× Tris-glycine–sodium dodecyl sulfate
T359	Noun_Phrase 11686 11694	1×TG-SDS
T360	Noun_Phrase 11704 11708	6E10
T361	Noun_Phrase 11713 11718	22C11
T362	Noun_Phrase 11720 11755	Amresco, Solon, Ohio, United States
T363	IDENTITY_chain 11720 11755	Amresco, Solon, Ohio, United States
T364	Noun_Phrase 11788 11792	CT15
T365	Noun_Phrase 11794 11841	Invitrogen, Carlsbad, California, United States
T366	Noun_Phrase 11844 11852	Proteins
T367	Noun_Phrase 11883 11914	0.45-?m Optitran nitrocellulose
T368	IDENTITY_chain 11883 11914	0.45-?m Optitran nitrocellulose
T369	Noun_Phrase 11916 11975	Schleicher and Schuell, Keene, New Hampshire, United States
T370	IDENTITY_chain 11916 11975	Schleicher and Schuell, Keene, New Hampshire, United States
T371	Noun_Phrase 11994 12001	Amresco
T372	Noun_Phrase 12004 12009	Blots
T373	IDENTITY_chain 12004 12009	Blots
T374	Noun_Phrase 12169 12174	mouse
T375	Noun_Phrase 12206 12245	Konrad Beyreuther and Andreas Weidemann
T376	IDENTITY_chain 12206 12245	Konrad Beyreuther and Andreas Weidemann
T377	Noun_Phrase 12270 12275	mouse
T378	Noun_Phrase 12369 12375	rabbit
T379	IDENTITY_chain 12369 12375	rabbit
T380	Noun_Phrase 12461 12467	rabbit
T381	Noun_Phrase 12498 12504	Ed Koo
T382	IDENTITY_chain 12498 12504	Ed Koo
T383	Noun_Phrase 12543 12552	the blots
T384	Noun_Phrase 12570 12598	PBS containing 0.1% Tween-20
T385	IDENTITY_chain 12570 12598	PBS containing 0.1% Tween-20
T386	Noun_Phrase 12631 12635	goat
T387	IDENTITY_chain 12631 12635	goat
T388	Noun_Phrase 12651 12655	goat
T389	Noun_Phrase 12721 12738	blocking solution
T390	IDENTITY_chain 12721 12738	blocking solution
T391	Noun_Phrase 12775 12797	PBS with 0.1% Tween-20
T392	Noun_Phrase 12799 12804	blots
T393	Noun_Phrase 12825 12851	enhanced chemiluminescence
T394	IDENTITY_chain 12825 12851	enhanced chemiluminescence
T395	Noun_Phrase 12876 12914	the Bio-Rad Molecular Imager FX system
T396	IDENTITY_chain 12876 12914	the Bio-Rad Molecular Imager FX system
T397	Noun_Phrase 12974 13014	the Quantity One image analysis software
T398	IDENTITY_chain 12974 13014	the Quantity One image analysis software
T399	Noun_Phrase 13016 13035	Molecular Imager FX
T400	Noun_Phrase 13037 13057	Bio-Rad Laboratories
T401	Noun_Phrase 13368 13373	brain
T402	Noun_Phrase 13459 13490	0.45-?m Optitran nitrocellulose
T403	Noun_Phrase 13548 13553	blots
T404	Noun_Phrase 13642 13653	mo/huAPP695
T405	Noun_Phrase 13642 13658	mo/huAPP695 cDNA
T406	Noun_Phrase 13769 13778	the blots
T407	Noun_Phrase 13992 13997	Blots
T408	Noun_Phrase 14059 14075	room temperature
T409	IDENTITY_chain 14059 14075	room temperature
T410	Noun_Phrase 14078 14085	Amyloid
T411	Noun_Phrase 14078 14095	Amyloid Histology
T412	IDENTITY_chain 14078 14095	Amyloid Histology
T413	Noun_Phrase 14097 14101	Mice
T414	Noun_Phrase 14142 14148	brains
T415	Noun_Phrase 14243 14249	brains
T416	Noun_Phrase 14270 14273	PBS
T417	IDENTITY_chain 14270 14273	PBS
T418	Noun_Phrase 14289 14297	alcohols
T419	IDENTITY_chain 14289 14297	alcohols
T420	Noun_Phrase 14364 14372	paraffin
T421	IDENTITY_chain 14364 14372	paraffin
T422	Noun_Phrase 14390 14396	Hirano
T423	IDENTITY_chain 14390 14396	Hirano
T424	Noun_Phrase 14390 14409	Hirano silver stain
T425	IDENTITY_chain 14390 14409	Hirano silver stain
T426	Noun_Phrase 14458 14490	10-?m paraffin-embedded sections
T427	IDENTITY_chain 14458 14490	10-?m paraffin-embedded sections
T428	Noun_Phrase 14494 14502	Hirano's
T429	Noun_Phrase 14558 14566	sections
T430	Noun_Phrase 14620 14629	tap water
T431	IDENTITY_chain 14620 14629	tap water
T432	Noun_Phrase 14736 14751	distilled water
T433	IDENTITY_chain 14736 14751	distilled water
T434	Noun_Phrase 14753 14759	slides
T435	IDENTITY_chain 14753 14759	slides
T436	Noun_Phrase 14859 14865	slides
T437	Noun_Phrase 14948 14957	developer
T438	Noun_Phrase 14959 15072	20 ml of 37% formaldehyde, 100 ml of distilled water, 50 ?l of concentrated nitric acid, and 0.5 g of citric acid
T439	APPOS_relation 14959 15072	20 ml of 37% formaldehyde, 100 ml of distilled water, 50 ?l of concentrated nitric acid, and 0.5 g of citric acid
T440	Noun_Phrase 15126 15132	Slides
T441	Noun_Phrase 15153 15162	tap water
T442	Noun_Phrase 15219 15227	alcohols
T443	Noun_Phrase 15232 15238	xylene
T444	IDENTITY_chain 15232 15238	xylene
T445	Noun_Phrase 15241 15253	Thioflavin-S
T446	IDENTITY_chain 15241 15253	Thioflavin-S
T447	Noun_Phrase 15295 15303	sections
T448	Noun_Phrase 15312 15318	xylene
T449	Noun_Phrase 15323 15331	alcohols
T450	Noun_Phrase 15333 15340	amyloid
T451	Noun_Phrase 15359 15371	thioflavin-S
T452	Noun_Phrase 15450 15488	Slides holding 10-?m paraffin sections
T453	IDENTITY_chain 15450 15488	Slides holding 10-?m paraffin sections
T454	Noun_Phrase 15465 15488	10-?m paraffin sections
T455	Noun_Phrase 15471 15479	paraffin
T456	Noun_Phrase 15510 15525	distilled water
T457	Noun_Phrase 15694 15700	slides
T458	Noun_Phrase 15895 15910	distilled water
T459	Noun_Phrase 15924 15930	slides
T460	Noun_Phrase 16007 16016	Ubiquitin
T461	IDENTITY_chain 16007 16016	Ubiquitin
T462	Noun_Phrase 16055 16057	A?
T463	Noun_Phrase 16055 16078	A? immunohistochemistry
T464	IDENTITY_chain 16055 16078	A? immunohistochemistry
T465	Noun_Phrase 16105 16111	slides
T466	Noun_Phrase 16173 16179	xylene
T467	Noun_Phrase 16228 16237	tap water
T468	Noun_Phrase 16336 16342	Slides
T469	Noun_Phrase 16374 16379	water
T470	Noun_Phrase 16414 16417	TBS
T471	IDENTITY_chain 16414 16417	TBS
T472	Noun_Phrase 16475 16479	goat
T473	Noun_Phrase 16511 16514	TBS
T474	Noun_Phrase 16516 16522	Slides
T475	Noun_Phrase 16545 16561	primary antibody
T476	Noun_Phrase 16563 16605;16675 16773	rabbit anti-A? peptide polyclonal antibody rabbit anti-ubiquitin and rabbit anti–glial fibrillary acidic protein (GFAP) polyclonal antibodies
T477	Noun_Phrase 16607 16673	Zymed Laboratories, South San Francisco, California, United States
T478	IDENTITY_chain 16607 16673	Zymed Laboratories, South San Francisco, California, United States
T479	Noun_Phrase 16713 16744	glial fibrillary acidic protein
T480	APPOS_relation 16713 16744	glial fibrillary acidic protein
T481	Noun_Phrase 16746 16750	GFAP
T482	Noun_Phrase 16857 16861	goat
T483	Noun_Phrase 16895 16911	room temperature
T484	Noun_Phrase 16983 16986	TBS
T485	Noun_Phrase 16988 16994	slides
T486	Noun_Phrase 17022 17071	the Vectastain Elite anti-rabbit secondary system
T487	Noun_Phrase 17073 17140	anti-A?; Vector Laboratories, Burlingame, California, United States
T488	Noun_Phrase 17145 17180	peroxidase/anti-peroxidase reagents
T489	Noun_Phrase 17182 17211	anti-ubitquitin and anti-GFAP
T490	Noun_Phrase 17320 17336	Antibody binding
T491	IDENTITY_chain 17320 17336	Antibody binding
T492	Noun_Phrase 17379 17387	sections
T493	Noun_Phrase 17427 17438	Filter Trap
T494	IDENTITY_chain 17427 17438	Filter Trap
T495	Noun_Phrase 17427 17444	Filter Trap Assay
T496	IDENTITY_chain 17427 17444	Filter Trap Assay
T497	Noun_Phrase 17562 17565	SDS
T498	IDENTITY_chain 17562 17565	SDS
T499	Noun_Phrase 17710 17754	a pre-wet 0.22-?m cellulose acetate membrane
T500	IDENTITY_chain 17710 17754	a pre-wet 0.22-?m cellulose acetate membrane
T501	Noun_Phrase 17756 17778	Schleicher and Schuell
T502	Noun_Phrase 17826 17829	PBS
T503	Noun_Phrase 17843 17848	blots
T504	Noun_Phrase 17908 17926	Zymed Laboratories
T505	Noun_Phrase 18016 18025	the blots
T506	Noun_Phrase 18057 18077	1× TBS/0.1% Tween-20
T507	IDENTITY_chain 18057 18077	1× TBS/0.1% Tween-20
T508	Noun_Phrase 18079 18091	the membrane
T509	Noun_Phrase 18145 18150	Sigma
T510	Noun_Phrase 18171 18188	blocking solution
T511	Noun_Phrase 18190 18203	The membranes
T512	Noun_Phrase 18239 18259	1× TBS/0.1% Tween-20
T513	Noun_Phrase 18268 18284	antibody binding
T514	Noun_Phrase 18303 18329	enhanced chemiluminescence
T515	Noun_Phrase 18432 18451	Molecular Imager FX
T516	Noun_Phrase 18499 18501	A?
T517	Noun_Phrase 18532 18568	Quantity One image analysis software
T518	Noun_Phrase 18571 18573	A?
T519	Noun_Phrase 18571 18579	A? ELISA
T520	IDENTITY_chain 18571 18579	A? ELISA
T521	Noun_Phrase 18720 18723	PBS
T522	Noun_Phrase 18720 18757	PBS, 2% SDS, and 70% formic acid (FA)
T523	IDENTITY_chain 18720 18757	PBS, 2% SDS, and 70% formic acid (FA)
T524	Noun_Phrase 18741 18752	formic acid
T525	APPOS_relation 18741 18752	formic acid
T526	Noun_Phrase 18754 18756	FA
T527	Noun_Phrase 18955 18970	The supernatant
T528	Noun_Phrase 18987 18995	analysis
T529	Noun_Phrase 19096 19105	EC buffer
T530	IDENTITY_chain 19096 19105	EC buffer
T531	Noun_Phrase 19115 19117	FA
T532	IDENTITY_chain 19115 19117	FA
T533	Noun_Phrase 19195 19204	EC buffer
T534	Noun_Phrase 19223 19231	Human A?
T535	IDENTITY_chain 19223 19231	Human A?
T536	Noun_Phrase 19307 19334	BA27 and BC05 for detection
T537	IDENTITY_chain 19307 19334	BA27 and BC05 for detection
T538	Noun_Phrase 19336 19340	A?40
T539	IDENTITY_chain 19336 19340	A?40
T540	Noun_Phrase 19336 19349	A?40 and A?42
T541	IDENTITY_chain 19336 19349	A?40 and A?42
T542	Noun_Phrase 19345 19349	A?42
T543	IDENTITY_chain 19345 19349	A?42
T544	Noun_Phrase 19366 19406	Takeda Chemical Industries, Osaka, Japan
T545	IDENTITY_chain 19366 19406	Takeda Chemical Industries, Osaka, Japan
T546	Noun_Phrase 19409 19417	Total A?
T547	IDENTITY_chain 19409 19417	Total A?
T548	Noun_Phrase 19427 19432	human
T549	Noun_Phrase 19537 19564	BA27 and BC05 for detection
T550	Noun_Phrase 19721 19792	28 CaMKII?-tTA × tet-APPswe/ind line 107 mice between 4 and 5 mo of age
T551	IDENTITY_chain 19721 19792	28 CaMKII?-tTA × tet-APPswe/ind line 107 mice between 4 and 5 mo of age
T552	Noun_Phrase 19794 19801	Animals
T553	Noun_Phrase 19822 19838	individual cages
T554	IDENTITY_chain 19822 19838	individual cages
T555	Noun_Phrase 19950 19959	The cages
T556	Noun_Phrase 20035 20045	the animal
T557	Noun_Phrase 20107 20115	the cage
T558	Noun_Phrase 20179 20190	Experiments
T559	IDENTITY_chain 20179 20190	Experiments
T560	Noun_Phrase 20251 20255	data
T561	IDENTITY_chain 20251 20255	data
T562	Noun_Phrase 20385 20391	animal
T563	Noun_Phrase 20438 20452	the experiment
T564	Noun_Phrase 20501 20508	protein
T565	Noun_Phrase 20521 20526	ELISA
T566	IDENTITY_chain 20521 20526	ELISA
T567	Noun_Phrase 20521 20531	ELISA data
T568	IDENTITY_chain 20521 20531	ELISA data
T569	Noun_Phrase 20537 20548	filter trap
T570	Noun_Phrase 20537 20555	filter trap assays
T571	Noun_Phrase 20890 20897	Results
T572	IDENTITY_chain 20890 20897	Results
T573	Noun_Phrase 20899 20901	We
T574	Noun_Phrase 20911 20918	tet-off
T575	Noun_Phrase 20974 20994	chimeric mo/huAPP695
T576	APPOS_relation 20974 20994	chimeric mo/huAPP695
T577	Noun_Phrase 20996 21027	swe/ind KM570, 571NL, and V617F
T578	Noun_Phrase 21078 21092	Transgenic APP
T579	Noun_Phrase 21078 21103	Transgenic APP expression
T580	Noun_Phrase 21134 21144	APPswe/ind
T581	IDENTITY_chain 21134 21144	APPswe/ind
T582	Noun_Phrase 21171 21212	tTA under control of the CaMKII? promoter
T583	Noun_Phrase 21192 21212	the CaMKII? promoter
T584	Noun_Phrase 21196 21203	CaMKII?
T585	Noun_Phrase 21246 21254	founders
T586	Noun_Phrase 21256 21258	we
T587	Noun_Phrase 21270 21385	four lines of tet-APPswe/ind mice that produced very high levels of transgene product in offspring coexpressing tTA
T588	IDENTITY_chain 21270 21385	four lines of tet-APPswe/ind mice that produced very high levels of transgene product in offspring coexpressing tTA
T589	Noun_Phrase 21338 21347	transgene
T590	Noun_Phrase 21382 21385	tTA
T591	Noun_Phrase 21387 21396	Figures 1
T592	IDENTITY_chain 21387 21396	Figures 1
T593	Noun_Phrase 21387 21410	Figures 1 and Figure S1
T594	IDENTITY_chain 21387 21410	Figures 1 and Figure S1
T595	Noun_Phrase 21401 21410	Figure S1
T596	IDENTITY_chain 21401 21410	Figure S1
T597	Noun_Phrase 21425 21507	a standard APP transgenic line used for previous amyloid studies by our laboratory
T598	APPOS_relation 21425 21507	a standard APP transgenic line used for previous amyloid studies by our laboratory
T599	IDENTITY_chain 21425 21507	a standard APP transgenic line used for previous amyloid studies by our laboratory
T600	Noun_Phrase 21509 21518	line C3–3
T601	Noun_Phrase 21533 21535	we
T602	Noun_Phrase 21551 21578	the four controllable lines
T603	Noun_Phrase 21587 21601	transgenic APP
T604	Noun_Phrase 21716 21719	APP
T605	Noun_Phrase 21730 21743;21760 21764	nontransgenic mice
T606	Noun_Phrase 21748 21764	tet-off APP mice
T607	IDENTITY_chain 21748 21764	tet-off APP mice
T608	Noun_Phrase 21771 21884	an antibody that recognizes both endogenous APP (and amyloid precursor-like protein 2) and the transgenic protein
T609	APPOS_relation 21771 21884	an antibody that recognizes both endogenous APP (and amyloid precursor-like protein 2) and the transgenic protein
T610	Noun_Phrase 21886 21911	monoclonal antibody 22C11
T611	Noun_Phrase 21913 21922	Figure 1D
T612	IDENTITY_chain 21913 21922	Figure 1D
T613	Noun_Phrase 21939 21977	all four new lines of tet-off APP mice
T614	Noun_Phrase 21961 21977	tet-off APP mice
T615	Noun_Phrase 22040 22043	dox
T616	Noun_Phrase 22040 22053	dox treatment
T617	IDENTITY_chain 22040 22053	dox treatment
T618	Noun_Phrase 22055 22064	Figures 1
T619	Noun_Phrase 22055 22078	Figures 1 and Figure S1
T620	Noun_Phrase 22069 22078	Figure S1
T621	Noun_Phrase 22081 22083	We
T622	Noun_Phrase 22095 22116	one of the four lines
T623	Noun_Phrase 22118 22126	line 107
T624	APPOS_relation 22118 22126	line 107
T625	IDENTITY_chain 22118 22126	line 107
T626	Noun_Phrase 22188 22197	transgene
T627	Noun_Phrase 22227 22232;22244 22262	acute treatment with dox
T628	IDENTITY_chain 22227 22232;22244 22262	acute treatment with dox
T629	Noun_Phrase 22236 22262	chronic treatment with dox
T630	IDENTITY_chain 22236 22262	chronic treatment with dox
T631	Noun_Phrase 22259 22262	dox
T632	Noun_Phrase 22264 22286	Two dox-treated groups
T633	IDENTITY_chain 22264 22286	Two dox-treated groups
T634	Noun_Phrase 22304 22324	two untreated groups
T635	IDENTITY_chain 22304 22324	two untreated groups
T636	Noun_Phrase 22326 22343	one group of mice
T637	IDENTITY_chain 22326 22343	one group of mice
T638	Noun_Phrase 22367 22370	dox
T639	Noun_Phrase 22372 22386	a second group
T640	IDENTITY_chain 22372 22386	a second group
T641	Noun_Phrase 22404 22407	dox
T642	Noun_Phrase 22454 22457	dox
T643	Noun_Phrase 22460 22500	two untreated groups kept on normal chow
T644	Noun_Phrase 22489 22500	normal chow
T645	IDENTITY_chain 22489 22500	normal chow
T646	Noun_Phrase 22544 22574	Animals born and raised on dox
T647	Noun_Phrase 22571 22574	dox
T648	Noun_Phrase 22603 22612	Figure 1A
T649	IDENTITY_chain 22603 22612	Figure 1A
T650	Noun_Phrase 22646 22649	dox
T651	Noun_Phrase 22646 22659	dox treatment
T652	Noun_Phrase 22661 22675	transgenic APP
T653	Noun_Phrase 22661 22686	transgenic APP expression
T654	Noun_Phrase 22781 22801	acutely treated mice
T655	Noun_Phrase 22879 22882	dox
T656	Noun_Phrase 22884 22893	Figure 1C
T657	IDENTITY_chain 22884 22893	Figure 1C
T658	Noun_Phrase 22966 22970	data
T659	Noun_Phrase 22996 23019	the total amount of APP
T660	Noun_Phrase 23021 23047	endogenous plus transgenic
T661	Noun_Phrase 23162 23180	nontransgenic mice
T662	Noun_Phrase 23182 23191	Figure 1D
T663	Noun_Phrase 23241 23250	the study
T664	Noun_Phrase 23318 23320	A?
T665	Noun_Phrase 23318 23331	A? production
T666	Noun_Phrase 23394 23397	its
T667	Noun_Phrase 23408 23418	APPswe/ind
T668	Noun_Phrase 23420 23422	we
T669	Noun_Phrase 23432 23436	A?40
T670	Noun_Phrase 23432 23445	A?40 and A?42
T671	Noun_Phrase 23441 23445	A?42
T672	Noun_Phrase 23465 23474	forebrain
T673	Noun_Phrase 23492 23513	young tet-off animals
T674	IDENTITY_chain 23492 23513	young tet-off animals
T675	Noun_Phrase 23498 23505	tet-off
T676	Noun_Phrase 23531 23539	the mice
T677	Noun_Phrase 23555 23562	amyloid
T678	Noun_Phrase 23657 23670	the transgene
T679	Noun_Phrase 23710 23712	we
T680	Noun_Phrase 23772 23775	our
T681	Noun_Phrase 23798 23805	peptide
T682	IDENTITY_chain 23798 23805	peptide
T683	Noun_Phrase 23817 23819	we
T684	Noun_Phrase 23870 23873	PBS
T685	Noun_Phrase 23870 23893	PBS, 2% SDS, and 70% FA
T686	Noun_Phrase 23914 23922	peptides
T687	Noun_Phrase 23938 23940	We
T688	Noun_Phrase 24005 24040	untreated mice at 4 and 6 wk of age
T689	Noun_Phrase 24044 24190	animals that had either been born and raised on dox or that had been left untreated for 4 wk and then placed on dox chow for 2 wk prior to harvest
T690	APPOS_relation 24044 24190	animals that had either been born and raised on dox or that had been left untreated for 4 wk and then placed on dox chow for 2 wk prior to harvest
T691	Noun_Phrase 24192 24278	the same groups described above for immunoblot analysis of APPswe/ind levels, line 107
T692	Noun_Phrase 24314 24336	full-length APPswe/ind
T693	IDENTITY_chain 24314 24336	full-length APPswe/ind
T694	Noun_Phrase 24356 24366	immunoblot
T695	IDENTITY_chain 24356 24366	immunoblot
T696	Noun_Phrase 24372 24380	Figure 1
T697	Noun_Phrase 24383 24385	we
T698	Noun_Phrase 24415 24417	A?
T699	Noun_Phrase 24455 24485	animals born and raised on dox
T700	Noun_Phrase 24482 24485	dox
T701	Noun_Phrase 24522 24555	acute (2 wk) antibiotic treatment
T702	Noun_Phrase 24535 24545	antibiotic
T703	Noun_Phrase 24583 24606	untreated 4-wk-old mice
T704	IDENTITY_chain 24583 24606	untreated 4-wk-old mice
T705	Noun_Phrase 24608 24624	PBS-soluble A?42
T706	IDENTITY_chain 24608 24624	PBS-soluble A?42
T707	Noun_Phrase 24652 24673	2 wk of dox treatment
T708	Noun_Phrase 24660 24663	dox
T709	Noun_Phrase 24660 24673	dox treatment
T710	Noun_Phrase 24692 24709	chronic treatment
T711	Noun_Phrase 24711 24720	Figure 2A
T712	IDENTITY_chain 24711 24720	Figure 2A
T713	Noun_Phrase 24790 24794;24807 24820	2-wk dox treatment
T714	Noun_Phrase 24798 24820	lifelong dox treatment
T715	Noun_Phrase 24807 24810	dox
T716	Noun_Phrase 24822 24831	Figure 2B
T717	IDENTITY_chain 24822 24831	Figure 2B
T718	Noun_Phrase 24843 24845	FA
T719	Noun_Phrase 24864 25054	a small dox-resistant pool of peptide in acutely treated animals that we believe represents stable predeposit aggregates that have already accumulated by 4 wk of age when treatment was begun
T720	IDENTITY_chain 24864 25054	a small dox-resistant pool of peptide in acutely treated animals that we believe represents stable predeposit aggregates that have already accumulated by 4 wk of age when treatment was begun
T721	Noun_Phrase 24934 24936	we
T722	Noun_Phrase 25056 25065	Figure 2C
T723	IDENTITY_chain 25056 25065	Figure 2C
T724	Noun_Phrase 25076 25116	animals that were born and raised on dox
T725	Noun_Phrase 25113 25116	dox
T726	Noun_Phrase 25132 25177	this reservoir of treatment-resistant peptide
T727	Noun_Phrase 25205 25228	untreated 4-wk-old mice
T728	Noun_Phrase 25257 25281	chronically treated mice
T729	Noun_Phrase 25366 25382	tet-off APP mice
T730	Noun_Phrase 25440 25461	nontransgenic animals
T731	Noun_Phrase 25463 25472	Figure 2D
T732	IDENTITY_chain 25463 25472	Figure 2D
T733	Noun_Phrase 25499 25513	immunoblotting
T734	Noun_Phrase 25523 25545	full-length APPswe/ind
T735	Noun_Phrase 25551 25556	ELISA
T736	Noun_Phrase 25612 25633	transgenic APPswe/ind
T737	IDENTITY_chain 25612 25633	transgenic APPswe/ind
T738	Noun_Phrase 25675 25677	A?
T739	Noun_Phrase 25675 25684	A? levels
T740	Noun_Phrase 25687 25701	The ELISA data
T741	Noun_Phrase 25691 25696	ELISA
T742	Noun_Phrase 25739 25742;25755 25772	the Indiana mutations
T743	Noun_Phrase 25739 25750;25763 25772	the Swedish mutations
T744	Noun_Phrase 25795 25799	A?42
T745	Noun_Phrase 25807 25809	we
T746	Noun_Phrase 25839 25845	plaque
T747	Noun_Phrase 25911 25928;25960 25964	double transgenic mice
T748	APPOS_relation 25911 25928;25960 25964	double transgenic mice
T749	IDENTITY_chain 25911 25928;25960 25964	double transgenic mice
T750	Noun_Phrase 25930 25958	CaMKII?-tTA × tet-APPswe/ind
T751	Noun_Phrase 25986 25993	amyloid
T752	Noun_Phrase 26007 26025	all four new lines
T753	Noun_Phrase 26027 26034	Amyloid
T754	Noun_Phrase 26027 26042	Amyloid plaques
T755	IDENTITY_chain 26027 26042	Amyloid plaques
T756	Noun_Phrase 26086 26090	data
T757	Noun_Phrase 26103 26110	Plaques
T758	Noun_Phrase 26127 26140	the forebrain
T759	Noun_Phrase 26152 26155;26164 26175	the hippocampus
T760	IDENTITY_chain 26152 26155;26164 26175	the hippocampus
T761	Noun_Phrase 26152 26162	the cortex
T762	IDENTITY_chain 26152 26162	the cortex
T763	Noun_Phrase 26213 26233	the CaMKII? promoter
T764	Noun_Phrase 26217 26224	CaMKII?
T765	Noun_Phrase 26270 26279	Figure S2
T766	IDENTITY_chain 26270 26279	Figure S2
T767	Noun_Phrase 26298 26305	amyloid
T768	Noun_Phrase 26298 26312	amyloid burden
T769	Noun_Phrase 26352 26355;26367 26378	the hippocampus
T770	Noun_Phrase 26352 26362	the cortex
T771	Noun_Phrase 26380 26389	Figure S3
T772	IDENTITY_chain 26380 26389	Figure S3
T773	Noun_Phrase 26434 26439	brain
T774	Noun_Phrase 26556 26573	the human disease
T775	IDENTITY_chain 26556 26573	the human disease
T776	Noun_Phrase 26604 26624	the tet-off APP mice
T777	Noun_Phrase 26655 26657	We
T778	Noun_Phrase 26731 26734	APP
T779	Noun_Phrase 26763 26783	the Swedish mutation
T780	Noun_Phrase 26790 26805	Diffuse plaques
T781	IDENTITY_chain 26790 26805	Diffuse plaques
T782	Noun_Phrase 26823 26844	6-mo-old tTA/APP mice
T783	IDENTITY_chain 26823 26844	6-mo-old tTA/APP mice
T784	Noun_Phrase 26896 26906	older ages
T785	Noun_Phrase 26908 26915	9–12 mo
T786	APPOS_relation 26908 26915	9–12 mo
T787	Noun_Phrase 26917 26924	amyloid
T788	Noun_Phrase 26917 26933	amyloid deposits
T789	Noun_Phrase 26950 26962	the thalamus
T790	IDENTITY_chain 26950 26962	the thalamus
T791	Noun_Phrase 27063 27070	amyloid
T792	Noun_Phrase 27186 27198	the thalamus
T793	Noun_Phrase 27228 27250	double transgenic mice
T794	Noun_Phrase 27263 27294	both the tTA and APP transgenes
T795	Noun_Phrase 27268 27271;27280 27294	the APP transgenes
T796	Noun_Phrase 27268 27275;27284 27294	the tTA transgenes
T797	Noun_Phrase 27272 27275	tTA
T798	Noun_Phrase 27280 27283	APP
T799	Noun_Phrase 27306 27313	amyloid
T800	Noun_Phrase 27306 27321	amyloid lesions
T801	Noun_Phrase 27394 27403	Figure S3
T802	Noun_Phrase 27417 27424	amyloid
T803	Noun_Phrase 27417 27434	amyloid pathology
T804	Noun_Phrase 27511 27514	dox
T805	Noun_Phrase 27529 27556	our highest expressing line
T806	APPOS_relation 27529 27556	our highest expressing line
T807	Noun_Phrase 27558 27566	line 885
T808	Noun_Phrase 27582 27585	dox
T809	Noun_Phrase 27612 27619	amyloid
T810	Noun_Phrase 27631 27635	data
T811	Noun_Phrase 27684 27693	transgene
T812	Noun_Phrase 27708 27727	the presence of dox
T813	IDENTITY_chain 27708 27727	the presence of dox
T814	Noun_Phrase 27724 27727	dox
T815	Noun_Phrase 27756 27758	A?
T816	Noun_Phrase 27777 27784	amyloid
T817	Noun_Phrase 27873 27875	A?
T818	Noun_Phrase 27873 27886	A? production
T819	Noun_Phrase 27888 27890	we
T820	Noun_Phrase 27898 27963	a group of 25 double transgenic mice (CaMKII?-tTA × APP line 107)
T821	IDENTITY_chain 27898 27963	a group of 25 double transgenic mice (CaMKII?-tTA × APP line 107)
T822	Noun_Phrase 27912 27934	double transgenic mice
T823	APPOS_relation 27912 27934	double transgenic mice
T824	Noun_Phrase 27936 27962	CaMKII?-tTA × APP line 107
T825	Noun_Phrase 27967 27978	normal food
T826	Noun_Phrase 28003 28005	we
T827	Noun_Phrase 28011 28018	amyloid
T828	Noun_Phrase 28058 28067	the brain
T829	Noun_Phrase 28078 28097	half of the animals
T830	IDENTITY_chain 28078 28097	half of the animals
T831	Noun_Phrase 28086 28097	the animals
T832	Noun_Phrase 28117 28128	normal chow
T833	Noun_Phrase 28171 28175	they
T834	Noun_Phrase 28214 28243	The remaining control animals
T835	IDENTITY_chain 28214 28243	The remaining control animals
T836	Noun_Phrase 28257 28270	standard chow
T837	Noun_Phrase 28272 28281	untreated
T838	Noun_Phrase 28292 28304	four cohorts
T839	IDENTITY_chain 28292 28304	four cohorts
T840	Noun_Phrase 28319 28333	6 mo untreated
T841	IDENTITY_chain 28319 28333	6 mo untreated
T842	Noun_Phrase 28343 28357	9 mo untreated
T843	IDENTITY_chain 28343 28357	9 mo untreated
T844	Noun_Phrase 28367 28386	6 mo + 3 mo treated
T845	IDENTITY_chain 28367 28386	6 mo + 3 mo treated
T846	Noun_Phrase 28400 28419	6 mo + 6 mo treated
T847	IDENTITY_chain 28400 28419	6 mo + 6 mo treated
T848	Noun_Phrase 28456 28477	transgenic APPswe/ind
T849	Noun_Phrase 28488 28511	the dox-treated animals
T850	Noun_Phrase 28529 28539	immunoblot
T851	Noun_Phrase 28567 28580	the transgene
T852	Noun_Phrase 28694 28696	we
T853	Noun_Phrase 28748 28751	dox
T854	Noun_Phrase 28797 28807	APPswe/ind
T855	Noun_Phrase 28884 28893	treatment
T856	Noun_Phrase 28936 28946	APPswe/ind
T857	Noun_Phrase 28951 28954	its
T858	Noun_Phrase 29008 29017	Figure 3D
T859	IDENTITY_chain 29008 29017	Figure 3D
T860	Noun_Phrase 29057 29082	the four treatment groups
T861	Noun_Phrase 29100 29107	amyloid
T862	Noun_Phrase 29100 29117	amyloid pathology
T863	Noun_Phrase 29121 29127	Hirano
T864	Noun_Phrase 29121 29134	Hirano silver
T865	Noun_Phrase 29136 29152	Campbell-Switzer
T866	IDENTITY_chain 29136 29152	Campbell-Switzer
T867	Noun_Phrase 29136 29159	Campbell-Switzer silver
T868	IDENTITY_chain 29136 29159	Campbell-Switzer silver
T869	Noun_Phrase 29161 29173	thioflavin-S
T870	Noun_Phrase 29179 29181	A?
T871	Noun_Phrase 29179 29202	A? immunohistochemistry
T872	Noun_Phrase 29217 29242	the 6 mo untreated cohort
T873	Noun_Phrase 29262 29269	amyloid
T874	Noun_Phrase 29285 29310	the 9 mo untreated cohort
T875	Noun_Phrase 29334 29341	amyloid
T876	Noun_Phrase 29377 29384	amyloid
T877	Noun_Phrase 29408 29411;29435 29462	the 6 mo + 6 mo treated cohorts
T878	Noun_Phrase 29408 29431;29455 29462	the 6 mo + 3 mo treated cohorts
T879	Noun_Phrase 29408 29462	the 6 mo + 3 mo treated or 6 mo + 6 mo treated cohorts
T880	IDENTITY_chain 29408 29462	the 6 mo + 3 mo treated or 6 mo + 6 mo treated cohorts
T881	Noun_Phrase 29489 29514	the 6 mo untreated cohort
T882	Noun_Phrase 29563 29566;29579 29595	the untreated groups
T883	Noun_Phrase 29563 29574;29589 29595	the treated groups
T884	Noun_Phrase 29597 29606	Figures 4
T885	IDENTITY_chain 29597 29606	Figures 4
T886	Noun_Phrase 29611 29620	Figure S3
T887	Noun_Phrase 29623 29642	Well-formed plaques
T888	IDENTITY_chain 29623 29642	Well-formed plaques
T889	Noun_Phrase 29689 29698	transgene
T890	Noun_Phrase 29689 29710	transgene suppression
T891	IDENTITY_chain 29689 29710	transgene suppression
T892	Noun_Phrase 29756 29767	the lesions
T893	Noun_Phrase 29771 29775	they
T894	Noun_Phrase 29805 29826	both types of amyloid
T895	APPOS_relation 29805 29826	both types of amyloid
T896	Noun_Phrase 29828 29849	diffuse and fibrillar
T897	Noun_Phrase 29878 29887	treatment
T898	Noun_Phrase 29895 29928	the Campbell-Switzer silver stain
T899	Noun_Phrase 29899 29915	Campbell-Switzer
T900	Noun_Phrase 29963 29970	amyloid
T901	Noun_Phrase 29972 29974	we
T902	Noun_Phrase 29981 29996	diffuse plaques
T903	Noun_Phrase 30035 30044	Figure S4
T904	IDENTITY_chain 30035 30044	Figure S4
T905	Nonreferential_pronoun 30047 30049	It
T906	Noun_Phrase 30105 30119	transgenic APP
T907	Noun_Phrase 30161 30170	pathology
T908	Noun_Phrase 30259 30276	the line 107 mice
T909	Noun_Phrase 30263 30271	line 107
T910	Noun_Phrase 30278 30280	we
T911	Noun_Phrase 30324 30357	a second line of tet-off APP mice
T912	APPOS_relation 30359 30395	CaMKII?-tTA × tet-APPswe/ind line 18
T913	IDENTITY_chain 30359 30395	CaMKII?-tTA × tet-APPswe/ind line 18
T914	Noun_Phrase 30359 30395	CaMKII?-tTA × tet-APPswe/ind line 18
T915	Noun_Phrase 30413 30436	long-term dox treatment
T916	Noun_Phrase 30467 30471	mice
T917	Noun_Phrase 30501 30510	transgene
T918	Noun_Phrase 30501 30522	transgene suppression
T919	Noun_Phrase 30618 30621	APP
T920	Noun_Phrase 30637 30646	transgene
T921	Noun_Phrase 30683 30692	Figure S5
T922	IDENTITY_chain 30683 30692	Figure S5
T923	Noun_Phrase 30701 30734	the line 107 mice described above
T924	Noun_Phrase 30705 30713	line 107
T925	Noun_Phrase 30736 30743	amyloid
T926	Noun_Phrase 30736 30750	amyloid burden
T927	Noun_Phrase 30823 30858	Suppression of transgene expression
T928	Noun_Phrase 30838 30847	transgene
T929	Noun_Phrase 30838 30858	transgene expression
T930	IDENTITY_chain 30838 30858	transgene expression
T931	Noun_Phrase 30892 30901	pathology
T932	Noun_Phrase 30903 30912	Figure S6
T933	IDENTITY_chain 30903 30912	Figure S6
T934	Noun_Phrase 31061 31063	We
T935	Noun_Phrase 31132 31135	our
T936	Noun_Phrase 31158 31167	transgene
T937	Noun_Phrase 31186 31197	filter trap
T938	Noun_Phrase 31259 31297	serial dilutions of protein homogenate
T939	IDENTITY_chain 31259 31297	serial dilutions of protein homogenate
T940	Noun_Phrase 31279 31286	protein
T941	Noun_Phrase 31279 31297	protein homogenate
T942	IDENTITY_chain 31279 31297	protein homogenate
T943	Noun_Phrase 31317 31343	a cellulose acetate filter
T944	IDENTITY_chain 31317 31343	a cellulose acetate filter
T945	Noun_Phrase 31384 31394	the filter
T946	Noun_Phrase 31446 31460	immunoblotting
T947	Noun_Phrase 31483 31486	our
T948	Noun_Phrase 31533 31585	line 107 tTA/APP mice treated with dox for 3 or 6 mo
T949	Noun_Phrase 31609 31622	aggregated A?
T950	IDENTITY_chain 31609 31622	aggregated A?
T951	Noun_Phrase 31631 31635	they
T952	Noun_Phrase 31670 31676;31684 31686	Figure 4B
T953	IDENTITY_chain 31670 31676;31684 31686	Figure 4B
T954	Noun_Phrase 31670 31679	Figure 4A
T955	IDENTITY_chain 31670 31679	Figure 4A
T956	Noun_Phrase 31702 31725	untreated 9-mo-old mice
T957	Noun_Phrase 31751 31764	aggregated A?
T958	Noun_Phrase 31778 31796	the treated groups
T959	Noun_Phrase 31798 31809	Filter trap
T960	Noun_Phrase 31822 31842	line 18 tTA/APP mice
T961	Noun_Phrase 31910 31953	untreated animals between 6 and 9 mo of age
T962	Noun_Phrase 31981 31990	transgene
T963	Noun_Phrase 31981 32002	transgene suppression
T964	Noun_Phrase 32004 32010;32019 32022	Figure S5D
T965	IDENTITY_chain 32004 32010;32019 32022	Figure S5D
T966	Noun_Phrase 32004 32014	Figure S5C
T967	IDENTITY_chain 32004 32014	Figure S5C
T968	Noun_Phrase 32026 32028	We
T969	Noun_Phrase 32039 32044	ELISA
T970	Noun_Phrase 32156 32163	peptide
T971	Noun_Phrase 32179 32189	APPswe/ind
T972	Noun_Phrase 32217 32237	Cortical homogenates
T973	IDENTITY_chain 32217 32237	Cortical homogenates
T974	Noun_Phrase 32278 32285	peptide
T975	Noun_Phrase 32291 32295;32310 32327	PBS- soluble fractions
T976	IDENTITY_chain 32291 32295;32310 32327	PBS- soluble fractions
T977	Noun_Phrase 32297 32301;32310 32327	SDS- soluble fractions
T978	IDENTITY_chain 32297 32301;32310 32327	SDS- soluble fractions
T979	Noun_Phrase 32307 32327	FA-soluble fractions
T980	IDENTITY_chain 32307 32327	FA-soluble fractions
T981	Noun_Phrase 32435 32442	amyloid
T982	Noun_Phrase 32435 32451	amyloid deposits
T983	Noun_Phrase 32453 32455	we
T984	Noun_Phrase 32488 32490	A?
T985	Noun_Phrase 32517 32520;32529 32541	the FA fractions
T986	Noun_Phrase 32517 32524;32532 32541	the SDS fractions
T987	Noun_Phrase 32521 32524	SDS
T988	Noun_Phrase 32529 32531	FA
T989	Noun_Phrase 32543 32549;32557 32559	Figure 5B
T990	IDENTITY_chain 32543 32549;32557 32559	Figure 5B
T991	Noun_Phrase 32543 32552	Figure 5A
T992	IDENTITY_chain 32543 32552	Figure 5A
T993	Noun_Phrase 32582 32593	filter trap
T994	Nonreferential_pronoun 32619 32624	there
T995	Noun_Phrase 32690 32715	the 6 mo untreated cohort
T996	Noun_Phrase 32720 32781	either the 6 mo + 3 mo treated or 6 mo + 6 mo treated cohorts
T997	Noun_Phrase 32727 32750;32774 32781	the 6 mo + 3 mo treated cohorts
T998	Noun_Phrase 32754 32781	6 mo + 6 mo treated cohorts
T999	Noun_Phrase 32802 32850	both 6 mo + 3 mo and 6 mo + 6 mo treated cohorts
T1000	IDENTITY_chain 32802 32850	both 6 mo + 3 mo and 6 mo + 6 mo treated cohorts
T1001	Noun_Phrase 32807 32818;32835 32850	6 mo + 3 mo treated cohorts
T1002	Noun_Phrase 32823 32850	6 mo + 6 mo treated cohorts
T1003	Noun_Phrase 32903 32926	untreated 6-mo-old mice
T1004	Noun_Phrase 32928 32937	Figure 5C
T1005	IDENTITY_chain 32928 32937	Figure 5C
T1006	Noun_Phrase 32950 32954	A?42
T1007	Noun_Phrase 33071 33086;33103 33118	the 6 mo + 3 mo treated cohorts
T1008	Noun_Phrase 33071 33118	the 6 mo + 3 mo and 6 mo + 6 mo treated cohorts
T1009	Noun_Phrase 33091 33118	6 mo + 6 mo treated cohorts
T1010	Noun_Phrase 33148 33173	the 9 mo untreated cohort
T1011	Noun_Phrase 33255 33274	the treated animals
T1012	Noun_Phrase 33341 33343	We
T1013	Noun_Phrase 33399 33410	the plaques
T1014	Nonreferential_pronoun 33432 33437	there
T1015	Noun_Phrase 33492 33501	transgene
T1016	Noun_Phrase 33520 33526	Hirano
T1017	Noun_Phrase 33520 33539	Hirano silver stain
T1018	Noun_Phrase 33544 33553	ubiquitin
T1019	Noun_Phrase 33598 33618	all treatment groups
T1020	Noun_Phrase 33620 33628	Figure 6
T1021	IDENTITY_chain 33620 33628	Figure 6
T1022	Noun_Phrase 33681 33685	GFAP
T1023	IDENTITY_chain 33681 33685	GFAP
T1024	Noun_Phrase 33726 33734	Figure 6
T1025	Noun_Phrase 33737 33765	Neuritic and glial pathology
T1026	IDENTITY_chain 33737 33765	Neuritic and glial pathology
T1027	Noun_Phrase 33786 33810	the older untreated mice
T1028	Noun_Phrase 33825 33834	transgene
T1029	Noun_Phrase 33825 33846	transgene suppression
T1030	Noun_Phrase 33903 33917	untreated mice
T1031	Noun_Phrase 33990 33999	treatment
T1032	Noun_Phrase 34028 34030	we
T1033	Noun_Phrase 34079 34081	A?
T1034	Noun_Phrase 34114 34128	untreated mice
T1035	Noun_Phrase 34277 34333	severe hyperactivity in untreated double transgenic mice
T1036	IDENTITY_chain 34277 34333	severe hyperactivity in untreated double transgenic mice
T1037	Noun_Phrase 34301 34333	untreated double transgenic mice
T1038	Noun_Phrase 34335 34354	The tTA/APP animals
T1039	Noun_Phrase 34414 34419	their
T1040	Noun_Phrase 34473 34481	the mice
T1041	Noun_Phrase 34497 34518	the Morris water maze
T1042	IDENTITY_chain 34497 34518	the Morris water maze
T1043	Noun_Phrase 34819 34822	our
T1044	Noun_Phrase 34847 34860	hyperactivity
T1045	Noun_Phrase 34888 34890	us
T1046	Noun_Phrase 34967 34973	APPswe
T1047	Noun_Phrase 34979 34981	we
T1048	Noun_Phrase 35005 35010;35019 35023	lines C3–3
T1049	Noun_Phrase 35136 35138	we
T1050	Noun_Phrase 35180 35187	amyloid
T1051	Noun_Phrase 35180 35192	amyloid load
T1052	IDENTITY_chain 35180 35192	amyloid load
T1053	Noun_Phrase 35233 35250	the current study
T1054	Noun_Phrase 35252 35254	we
T1055	Noun_Phrase 35298 35314	the tTA/APP mice
T1056	Noun_Phrase 35386 35397	the animals
T1057	Noun_Phrase 35386 35419	the animals' severe hyperactivity
T1058	Noun_Phrase 35524 35557	hyperactivity in the tTA/APP mice
T1059	Noun_Phrase 35541 35557	the tTA/APP mice
T1060	Noun_Phrase 35559 35561	we
T1061	Noun_Phrase 35598 35623	double transgenic animals
T1062	Noun_Phrase 35635 35640;35663 35685	their nontransgenic siblings
T1063	IDENTITY_chain 35635 35640;35663 35685	their nontransgenic siblings
T1064	Noun_Phrase 35635 35640	their
T1065	Noun_Phrase 35635 35658;35677 35685	their single transgenic siblings
T1066	IDENTITY_chain 35635 35658;35677 35685	their single transgenic siblings
T1067	Noun_Phrase 35777 35785	Figure 7
T1068	IDENTITY_chain 35777 35785	Figure 7
T1069	Noun_Phrase 35787 35813	the double transgenic mice
T1070	Noun_Phrase 36082 36098	the tTA/APP mice
T1071	Noun_Phrase 36223 36232	transgene
T1072	Noun_Phrase 36273 36277	data
T1073	Noun_Phrase 36303 36316	hyperactivity
T1074	Noun_Phrase 36369 36372	dox
T1075	Noun_Phrase 36374 36404	Animals born and raised on dox
T1076	Noun_Phrase 36401 36404	dox
T1077	Noun_Phrase 36439 36461	the untreated controls
T1078	Noun_Phrase 36463 36472	Figure 7C
T1079	IDENTITY_chain 36463 36472	Figure 7C
T1080	Noun_Phrase 36489 36518	all of the dox-reared animals
T1081	IDENTITY_chain 36489 36518	all of the dox-reared animals
T1082	Noun_Phrase 36618 36623	their
T1083	Noun_Phrase 36673 36675	We
T1084	Noun_Phrase 36684 36816	a new mouse model for AD that was designed to test the consequences of inhibiting A? production after the onset of amyloid pathology
T1085	IDENTITY_chain 36684 36816	a new mouse model for AD that was designed to test the consequences of inhibiting A? production after the onset of amyloid pathology
T1086	Noun_Phrase 36690 36695	mouse
T1087	Noun_Phrase 36706 36708	AD
T1088	Noun_Phrase 36766 36768	A?
T1089	Noun_Phrase 36799 36806	amyloid
T1090	Noun_Phrase 36799 36816	amyloid pathology
T1091	Noun_Phrase 36866 36876	this study
T1092	Noun_Phrase 36973 36975	We
T1093	Noun_Phrase 36993 37011	treatment with dox
T1094	Noun_Phrase 37008 37011	dox
T1095	Noun_Phrase 37051 37061	APPswe/ind
T1096	Noun_Phrase 37066 37069	its
T1097	Noun_Phrase 37196 37206	APPswe/ind
T1098	Noun_Phrase 37240 37244	A?42
T1099	Noun_Phrase 37263 37270	amyloid
T1100	Noun_Phrase 37285 37299	untreated mice
T1101	Noun_Phrase 37310 37318	deposits
T1102	Noun_Phrase 37351 37358	Amyloid
T1103	Noun_Phrase 37351 37365	Amyloid burden
T1104	Noun_Phrase 37441 37455	untreated mice
T1105	Noun_Phrase 37500 37502	We
T1106	Noun_Phrase 37528 37542	transgenic APP
T1107	Noun_Phrase 37594 37601	amyloid
T1108	Noun_Phrase 37594 37611	amyloid pathology
T1109	Noun_Phrase 37688 37695	amyloid
T1110	Noun_Phrase 37784 37793	secretase
T1111	Noun_Phrase 37784 37804	secretase inhibitors
T1112	Noun_Phrase 37829 37831	we
T1113	Noun_Phrase 37868 37885	deposited amyloid
T1114	IDENTITY_chain 37868 37885	deposited amyloid
T1115	Noun_Phrase 37912 37921	transgene
T1116	Noun_Phrase 37912 37933	transgene suppression
T1117	Noun_Phrase 37962 37969	plaques
T1118	Noun_Phrase 38222 38233	?-secretase
T1119	Noun_Phrase 38294 38296	A?
T1120	Noun_Phrase 38346 38348	we
T1121	Noun_Phrase 38405 38449	Tg2576 [33] and TgCRND8 [34] transgenic mice
T1122	IDENTITY_chain 38405 38449	Tg2576 [33] and TgCRND8 [34] transgenic mice
T1123	Noun_Phrase 38487 38491	A?40
T1124	Noun_Phrase 38545 38549	A?42
T1125	Noun_Phrase 38627 38630	APP
T1126	Noun_Phrase 38627 38641	APP expression
T1127	IDENTITY_chain 38627 38641	APP expression
T1128	Noun_Phrase 38652 38655	our
T1129	Noun_Phrase 38669 38697	the Tg2576 and TgCRND8 lines
T1130	Noun_Phrase 38699 38701	we
T1131	Noun_Phrase 38747 38749	A?
T1132	Noun_Phrase 38766 38784	the tet-off system
T1133	Noun_Phrase 38770 38777	tet-off
T1134	Noun_Phrase 38827 38838	?-secretase
T1135	Noun_Phrase 38957 38959	A?
T1136	Noun_Phrase 38957 38970	A? production
T1137	Noun_Phrase 38991 39002	this system
T1138	Noun_Phrase 39112 39119	amyloid
T1139	Noun_Phrase 39112 39130	amyloid deposition
T1140	IDENTITY_chain 39112 39130	amyloid deposition
T1141	Noun_Phrase 39170 39172	we
T1142	Noun_Phrase 39198 39205	amyloid
T1143	Noun_Phrase 39249 39258	transgene
T1144	Noun_Phrase 39249 39270	transgene suppression
T1145	Noun_Phrase 39272 39274	We
T1146	Noun_Phrase 39325 39328	dox
T1147	Noun_Phrase 39325 39338	dox treatment
T1148	Noun_Phrase 39382 39389	amyloid
T1149	Noun_Phrase 39382 39398	amyloid deposits
T1150	Noun_Phrase 39520 39525	ELISA
T1151	Noun_Phrase 39548 39551	dox
T1152	Noun_Phrase 39587 39601	PBS-soluble A?
T1153	IDENTITY_chain 39587 39601	PBS-soluble A?
T1154	Noun_Phrase 39607 39615	Figure 5
T1155	IDENTITY_chain 39607 39615	Figure 5
T1156	Noun_Phrase 39665 39676	the plaques
T1157	Noun_Phrase 39797 39799	A?
T1158	Noun_Phrase 39797 39810	A? production
T1159	Noun_Phrase 39874 39881	amyloid
T1160	Noun_Phrase 39938 39947	the model
T1161	Noun_Phrase 40004 40010	humans
T1162	Noun_Phrase 40215 40217	we
T1163	Noun_Phrase 40228 40231	our
T1164	Noun_Phrase 40258 40260	AD
T1165	Noun_Phrase 40296 40316	the production of A?
T1166	Noun_Phrase 40314 40316	A?
T1167	Noun_Phrase 40339 40348	secretase
T1168	Noun_Phrase 40372 40375	APP
T1169	Noun_Phrase 40372 40386	APP expression
T1170	Noun_Phrase 40485 40492	amyloid
T1171	Noun_Phrase 40511 40514	our
T1172	Noun_Phrase 40511 40520	our study
T1173	Nonreferential_pronoun 40522 40524	it
T1174	Noun_Phrase 40585 40595	these mice
T1175	Noun_Phrase 40608 40611	APP
T1176	Noun_Phrase 40634 40654	the Swedish mutation
T1177	Noun_Phrase 40794 40811	the human disease
T1178	Noun_Phrase 40822 40825	our
T1179	Noun_Phrase 40849 40865	diffuse deposits
T1180	IDENTITY_chain 40849 40865	diffuse deposits
T1181	Noun_Phrase 40880 40890	these mice
T1182	Noun_Phrase 40892 40896	they
T1183	Noun_Phrase 40927 40930	our
T1184	Noun_Phrase 40927 40937	our system
T1185	IDENTITY_chain 40927 40937	our system
T1186	Noun_Phrase 40962 40971	Figure S4
T1187	Noun_Phrase 41002 41004	we
T1188	Noun_Phrase 41041 41050	transgene
T1189	Noun_Phrase 41041 41061	transgene expression
T1190	Noun_Phrase 41075 41094	the presence of dox
T1191	Noun_Phrase 41091 41094	dox
T1192	Noun_Phrase 41104 41123	endogenous mouse A?
T1193	IDENTITY_chain 41104 41123	endogenous mouse A?
T1194	Noun_Phrase 41115 41120	mouse
T1195	Nonreferential_pronoun 41150 41152	It
T1196	Noun_Phrase 41170 41248	the combined low levels of endogenous mouse A? and nonsuppressed human peptide
T1197	IDENTITY_chain 41170 41248	the combined low levels of endogenous mouse A? and nonsuppressed human peptide
T1198	Noun_Phrase 41197 41216	endogenous mouse A?
T1199	Noun_Phrase 41208 41213	mouse
T1200	Noun_Phrase 41304 41331	these low levels of peptide
T1201	Noun_Phrase 41365 41372	amyloid
T1202	Noun_Phrase 41430 41433	dox
T1203	Noun_Phrase 41466 41473	amyloid
T1204	Noun_Phrase 41466 41481	amyloid lesions
T1205	Noun_Phrase 41483 41487	data
T1206	Nonreferential_pronoun 41500 41502	It
T1207	Noun_Phrase 41525 41544	this genetic system
T1208	Noun_Phrase 41546 41548	we
T1209	Noun_Phrase 41561 41581	the production of A?
T1210	Noun_Phrase 41579 41581	A?
T1211	Noun_Phrase 41605 41611	humans
T1212	Noun_Phrase 41626 41635	pathology
T1213	Noun_Phrase 41680 41691	This system
T1214	Noun_Phrase 41700 41702	us
T1215	Noun_Phrase 41846 41856;41875 41887	aggregated states of A?
T1216	Noun_Phrase 41885 41887	A?
T1217	Noun_Phrase 41921 41928	amyloid
T1218	Noun_Phrase 41921 41937	amyloid deposits
T1219	Noun_Phrase 41942 41945	our
T1220	Nonreferential_pronoun 41955 41957	it
T1221	Noun_Phrase 41978 41985	amyloid
T1222	Noun_Phrase 41998 42009	human brain
T1223	IDENTITY_chain 41998 42009	human brain
T1224	Noun_Phrase 42067 42072	mouse
T1225	Noun_Phrase 42067 42078	mouse brain
T1226	IDENTITY_chain 42067 42078	mouse brain
T1227	Noun_Phrase 42089 42104	the human brain
T1228	Noun_Phrase 42151 42155	mice
T1229	Noun_Phrase 42254 42261	amyloid
T1230	Noun_Phrase 42297 42314	the human disease
T1231	Noun_Phrase 42327 42332	mouse
T1232	Noun_Phrase 42398 42414	transgenic mouse
T1233	Noun_Phrase 42398 42421	transgenic mouse models
T1234	Noun_Phrase 42453 42460	plaques
T1235	Noun_Phrase 42489 42496	amyloid
T1236	Noun_Phrase 42552 42559	amyloid
T1237	Noun_Phrase 42571 42582	human brain
T1238	Noun_Phrase 42706 42713	amyloid
T1239	Noun_Phrase 42737 42754	transgenic models
T1240	Noun_Phrase 42767 42786	the human condition
T1241	Noun_Phrase 42940 42947	amyloid
T1242	Noun_Phrase 42956 42959	APP
T1243	Noun_Phrase 42956 42975	APP transgenic mice
T1244	IDENTITY_chain 42956 42975	APP transgenic mice
T1245	Noun_Phrase 42999 43004	mouse
T1246	Noun_Phrase 43051 43058	amyloid
T1247	Noun_Phrase 43185 43196	?-secretase
T1248	Noun_Phrase 43253 43298	both the human condition and the mouse models
T1249	IDENTITY_chain 43253 43298	both the human condition and the mouse models
T1250	Noun_Phrase 43258 43277	the human condition
T1251	Noun_Phrase 43282 43298	the mouse models
T1252	Noun_Phrase 43370 43377	the two
T1253	Noun_Phrase 43413 43420	amyloid
T1254	Noun_Phrase 43413 43433;43484 43504	amyloid clearance in the tet-off APP mice
T1255	IDENTITY_chain 43413 43433;43484 43504	amyloid clearance in the tet-off APP mice
T1256	Noun_Phrase 43448 43464	patients with AD
T1257	Noun_Phrase 43462 43464	AD
T1258	Noun_Phrase 43470 43472	we
T1259	Noun_Phrase 43484 43504	the tet-off APP mice
T1260	Noun_Phrase 43549 43595	microglia in other mouse models of amyloidosis
T1261	IDENTITY_chain 43549 43595	microglia in other mouse models of amyloidosis
T1262	Noun_Phrase 43568 43573	mouse
T1263	Noun_Phrase 43597 43599	we
T1264	Noun_Phrase 43623 43634	these cells
T1265	Noun_Phrase 43663 43670	amyloid
T1266	Noun_Phrase 43663 43704	amyloid clearance in the tet-off APP mice
T1267	Noun_Phrase 43684 43704	the tet-off APP mice
T1268	Noun_Phrase 43715 43717	we
T1269	Noun_Phrase 43750 43771	chronic dox treatment
T1270	Noun_Phrase 43758 43761	dox
T1271	Noun_Phrase 43826 43829	our
T1272	Noun_Phrase 43826 43842	our treated mice
T1273	Noun_Phrase 43844 43847	Dox
T1274	Noun_Phrase 43875 43886	minocycline
T1275	APPOS_relation 43875 43886	minocycline
T1276	Noun_Phrase 43888 43960	a reported anti-inflammatory drug and inhibitor of microglial activation
T1277	Noun_Phrase 43979 43982	dox
T1278	Noun_Phrase 44085 44087	we
T1279	Noun_Phrase 44116 44155	less amyloid in the dox-treated animals
T1280	IDENTITY_chain 44116 44155	less amyloid in the dox-treated animals
T1281	Noun_Phrase 44132 44155	the dox-treated animals
T1282	Noun_Phrase 44166 44170	that
T1283	Nonreferential_pronoun 44195 44197	it
T1284	Noun_Phrase 44215 44218	dox
T1285	Noun_Phrase 44250 44257	amyloid
T1286	Noun_Phrase 44355 44374	the mouse AD models
T1287	Noun_Phrase 44359 44364	mouse
T1288	Nonreferential_pronoun 44393 44395	it
T1289	Noun_Phrase 44472 44475	our
T1290	Noun_Phrase 44472 44481	our study
T1291	Noun_Phrase 44517 44524	amyloid
T1292	Noun_Phrase 44537 44540	our
T1293	Noun_Phrase 44537 44547	our system
T1294	Noun_Phrase 44589 44591	A?
T1295	Noun_Phrase 44589 44602	A? aggregates
T1296	Noun_Phrase 44624 44629	mouse
T1297	Noun_Phrase 44708 44717	the brain
T1298	Noun_Phrase 44747 44754	amyloid
T1299	Noun_Phrase 44747 44763	amyloid deposits
T1300	Noun_Phrase 44810 44839	Peripheral antibody injection
T1301	IDENTITY_chain 44810 44839	Peripheral antibody injection
T1302	Noun_Phrase 44850 44857	amyloid
T1303	Noun_Phrase 44850 44862	amyloid load
T1304	Noun_Phrase 44890 44892	it
T1305	Noun_Phrase 44972 44979	amyloid
T1306	Noun_Phrase 45104 45114	neprilysin
T1307	IDENTITY_chain 45104 45114	neprilysin
T1308	Noun_Phrase 45245 45276	the antibody-mediated therapies
T1309	IDENTITY_chain 45245 45276	the antibody-mediated therapies
T1310	Nonreferential_pronoun 45415 45417	it
T1311	Noun_Phrase 45450 45465	the Fc receptor
T1312	APPOS_relation 45450 45465	the Fc receptor
T1313	Noun_Phrase 45467 45545	the primary receptor for microglial opsinization of antibody–antigen complexes
T1314	Noun_Phrase 45550 45577	APP transgenic mouse models
T1315	Noun_Phrase 45616 45641	antibody-mediated therapy
T1316	Nonreferential_pronoun 45651 45653	It
T1317	Noun_Phrase 46110 46120	neprilysin
T1318	Noun_Phrase 46396 46402	plaque
T1319	Noun_Phrase 46413 46432	APP transgenic mice
T1320	Noun_Phrase 46647 46654	amyloid
T1321	Noun_Phrase 46647 46664	amyloid pathology
T1322	Noun_Phrase 46772 46777	mouse
T1323	Noun_Phrase 46858 46864	humans
T1324	Noun_Phrase 46867 46883	SantaCruz et al.
T1325	IDENTITY_chain 46867 46883	SantaCruz et al.
T1326	Noun_Phrase 46903 46975	a study of mice that express P301L human tau via a similar vector system
T1327	IDENTITY_chain 46903 46975	a study of mice that express P301L human tau via a similar vector system
T1328	Noun_Phrase 46914 46975	mice that express P301L human tau via a similar vector system
T1329	IDENTITY_chain 46914 46975	mice that express P301L human tau via a similar vector system
T1330	Noun_Phrase 46988 46991	our
T1331	Noun_Phrase 46988 47008	our tet-off APP mice
T1332	Noun_Phrase 47010 47026	SantaCruz et al.
T1333	Noun_Phrase 47038 47041	tau
T1334	IDENTITY_chain 47038 47041	tau
T1335	Noun_Phrase 47072 47079	amyloid
T1336	Noun_Phrase 47072 47087	amyloid plaques
T1337	Noun_Phrase 47127 47136	transgene
T1338	Noun_Phrase 47127 47148	transgene suppression
T1339	Noun_Phrase 47190 47192	AD
T1340	Noun_Phrase 47253 47260	protein
T1341	Noun_Phrase 47289 47296	tet-off
T1342	Noun_Phrase 47436 47445	transgene
T1343	Noun_Phrase 47495 47502	protein
T1344	Noun_Phrase 47528 47531	our
T1345	Noun_Phrase 47528 47537	our study
T1346	Noun_Phrase 47542 47566	that of SantaCruz et al.
T1347	Noun_Phrase 47550 47566	SantaCruz et al.
T1348	Noun_Phrase 47580 47587	protein
T1349	Noun_Phrase 47602 47604	AD
T1350	Noun_Phrase 47695 47697	A?
T1351	Noun_Phrase 47702 47705	tau
T1352	Noun_Phrase 47751 47758	protein
T1353	Noun_Phrase 47852 47854	we
T1354	Noun_Phrase 47883 47893	this study
T1355	Noun_Phrase 47993 48013	the tet-off tau mice
T1356	Noun_Phrase 48027 48034	protein
T1357	Noun_Phrase 48109 48118	transgene
T1358	Noun_Phrase 48109 48130	transgene suppression
T1359	Nonreferential_pronoun 48210 48212	it
T1360	Noun_Phrase 48234 48254	the tet-off APP mice
T1361	Noun_Phrase 48314 48321	amyloid
T1362	Noun_Phrase 48314 48331	amyloid pathology
T1363	Noun_Phrase 48360 48362	we
T1364	Noun_Phrase 48474 48482	Figure 7
T1365	Noun_Phrase 48493 48519	the double transgenic mice
T1366	Noun_Phrase 48606 48627	the Morris water maze
T1367	Noun_Phrase 48719 48732	Hyperactivity
T1368	IDENTITY_chain 48719 48732	Hyperactivity
T1369	Noun_Phrase 48852 48854	We
T1370	Noun_Phrase 48898 48911	hyperactivity
T1371	Noun_Phrase 48942 48968	the APPswe/ind holoprotein
T1372	IDENTITY_chain 48942 48968	the APPswe/ind holoprotein
T1373	Noun_Phrase 48946 48956	APPswe/ind
T1374	Noun_Phrase 48972 48975	its
T1375	Noun_Phrase 49034 49047	hyperactivity
T1376	Noun_Phrase 49128 49135	J. L. J
T1377	IDENTITY_chain 49128 49135	J. L. J
T1378	Noun_Phrase 49138 49154	unpublished data
T1379	IDENTITY_chain 49138 49154	unpublished data
T1380	Noun_Phrase 49157 49167	These data
T1381	Noun_Phrase 49243 49257	transgenic APP
T1382	Noun_Phrase 49338 49351	hyperactivity
T1383	Noun_Phrase 49397 49406	transgene
T1384	Noun_Phrase 49542 49544	we
T1385	Noun_Phrase 49573 49575	A?
T1386	Noun_Phrase 49573 49586	A? production
T1387	Noun_Phrase 49730 49732	A?
T1388	Nonreferential_pronoun 49825 49827	It
T1389	Noun_Phrase 49881 49883	A?
T1390	Noun_Phrase 49881 49894	A? production
T1391	Noun_Phrase 49905 49907	A?
T1392	Noun_Phrase 49949 49966	deposited amyloid
T1393	Noun_Phrase 50017 50019	AD
T1394	Noun_Phrase 50071 50078	disease
T1395	Noun_Phrase 50080 50089	secretase
T1396	Noun_Phrase 50080 50106	secretase inhibitors alone
T1397	Noun_Phrase 50183 50201	amyloid deposition
T1398	Noun_Phrase 50227 50238	the disease
T1399	Noun_Phrase 50293 50301	human AD
T1400	Noun_Phrase 50357 50364	amyloid
T1401	Noun_Phrase 50485 50494	secretase
T1402	Noun_Phrase 50555 50570	the human brain
T1403	Noun_Phrase 50627 50629	AD
T1404	Noun_Phrase 50654 50663	pathology
T1405	Noun_Phrase 50702 50711	Figure S1
T1406	Noun_Phrase 50713 50727	Transgenic APP
T1407	Noun_Phrase 50765 50795	the Four New Tet-Off APP Lines
T1408	Noun_Phrase 50819 50847	human-specific antibody 6E10
T1409	Noun_Phrase 50965 50978	The new lines
T1410	Noun_Phrase 51016 51025	transgene
T1411	Noun_Phrase 51016 51036	transgene expression
T1412	Noun_Phrase 51057 51062	brain
T1413	Noun_Phrase 51090 51104	transgenic APP
T1414	Noun_Phrase 51201 51204	dox
T1415	Noun_Phrase 51201 51214	dox treatment
T1416	Noun_Phrase 51238 51268	all four new tet-off APP lines
T1417	Noun_Phrase 51377 51381	data
T1418	Noun_Phrase 51389 51398	Figure S2
T1419	Noun_Phrase 51400 51414	Transgenic APP
T1420	Noun_Phrase 51502 51532	the four new tet-off APP lines
T1421	Noun_Phrase 51639 51648	the brain
T1422	Noun_Phrase 51748 51752	data
T1423	Noun_Phrase 51760 51769	Figure S3
T1424	Noun_Phrase 51771 51778	Amyloid
T1425	Noun_Phrase 51771 51802	Amyloid Pathology in the Cortex
T1426	IDENTITY_chain 51771 51802	Amyloid Pathology in the Cortex
T1427	Noun_Phrase 51792 51802	the Cortex
T1428	Noun_Phrase 51822 51837	the Hippocampus
T1429	Noun_Phrase 51839 51846	Amyloid
T1430	Noun_Phrase 51839 51856	Amyloid histology
T1431	Noun_Phrase 51888 51896	line 107
T1432	Noun_Phrase 51888 51919	line 107 double transgenic mice
T1433	Noun_Phrase 51923 51929	Hirano
T1434	Noun_Phrase 51923 51942	Hirano silver stain
T1435	Noun_Phrase 51954 51966	thioflavin-S
T1436	Noun_Phrase 51985 51987	A?
T1437	Noun_Phrase 51985 52008	A? immunohistochemistry
T1438	Noun_Phrase 52072 52081	transgene
T1439	Noun_Phrase 52072 52093	transgene suppression
T1440	Noun_Phrase 52101 52116	the hippocampus
T1441	Noun_Phrase 52122 52130	Figure 4
T1442	Noun_Phrase 52142 52192	the progression of amyloid pathology in the cortex
T1443	IDENTITY_chain 52142 52192	the progression of amyloid pathology in the cortex
T1444	Noun_Phrase 52161 52168	amyloid
T1445	Noun_Phrase 52161 52192	amyloid pathology in the cortex
T1446	Noun_Phrase 52182 52192	the cortex
T1447	Noun_Phrase 52244 52258	untreated mice
T1448	Noun_Phrase 52260 52276	This progression
T1449	Noun_Phrase 52319 52332	the transgene
T1450	Noun_Phrase 52338 52341	dox
T1451	Noun_Phrase 52408 52425	single transgenic
T1452	Noun_Phrase 52427 52435	tTA only
T1453	Noun_Phrase 52448 52455	amyloid
T1454	Noun_Phrase 52593 52597	data
T1455	Noun_Phrase 52605 52614	Figure S4
T1456	Noun_Phrase 52616 52632	Diffuse Deposits
T1457	Noun_Phrase 52656 52658	A?
T1458	Noun_Phrase 52656 52670	A? Suppression
T1459	IDENTITY_chain 52656 52670	A? Suppression
T1460	Noun_Phrase 52672 52688	Campbell–Switzer
T1461	Noun_Phrase 52672 52701	Campbell–Switzer silver stain
T1462	Noun_Phrase 52775 52783	line 107
T1463	Noun_Phrase 52775 52796	line 107 tTA/APP mice
T1464	Noun_Phrase 52798 52808	This stain
T1465	Noun_Phrase 52884 52893	transgene
T1466	Noun_Phrase 52884 52905	transgene suppression
T1467	Noun_Phrase 53073 53075	A?
T1468	Noun_Phrase 53073 53087	A? suppression
T1469	Noun_Phrase 53230 53242	treated mice
T1470	Noun_Phrase 53334 53350	Campbell-Switzer
T1471	Noun_Phrase 53627 53631	data
T1472	Noun_Phrase 53639 53648	Figure S5
T1473	Noun_Phrase 53639 53648;53801 53802	Figure S5 A
T1474	IDENTITY_chain 53639 53648;53801 53802	Figure S5 A
T1475	Noun_Phrase 53639 53648;54337 54338	Figure S5 A
T1476	Noun_Phrase 53639 53648;54604 54605	Figure S5 C
T1477	Noun_Phrase 53639 53648;54703 54704	Figure S5 D
T1478	Noun_Phrase 53639 53648;54792 54793	Figure S5 C
T1479	Noun_Phrase 53658 53667	Transgene
T1480	Noun_Phrase 53694 53696	A?
T1481	Noun_Phrase 53720 53759	an Independent Line of Tet-Off APP Mice
T1482	Noun_Phrase 53761 53797	CaMKII?-tTA × tet-APPswe/ind Line 18
T1483	APPOS_relation 53761 53797	CaMKII?-tTA × tet-APPswe/ind Line 18
T1484	Noun_Phrase 53804 53865	The experiment presented in the text for line 107 tet-off APP
T1485	Noun_Phrase 53845 53865	line 107 tet-off APP
T1486	Noun_Phrase 53884 53909	a second tet-off APP line
T1487	APPOS_relation 53884 53909	a second tet-off APP line
T1488	IDENTITY_chain 53884 53909	a second tet-off APP line
T1489	Noun_Phrase 53911 53918	line 18
T1490	Noun_Phrase 53989 54006;54041 54045	untreated control mice
T1491	Noun_Phrase 54011 54045	dox-treated double transgenic mice
T1492	Noun_Phrase 54090 54122	the human-specific antibody 6E10
T1493	Noun_Phrase 54134 54143	transgene
T1494	Noun_Phrase 54199 54230	endogenous superoxide dismutase
T1495	IDENTITY_chain 54199 54230	endogenous superoxide dismutase
T1496	Noun_Phrase 54210 54230	superoxide dismutase
T1497	APPOS_relation 54210 54230	superoxide dismutase
T1498	Noun_Phrase 54232 54236	SOD1
T1499	Noun_Phrase 54371 54378	line 18
T1500	Noun_Phrase 54429 54432	dox
T1501	Noun_Phrase 54429 54442	dox treatment
T1502	Noun_Phrase 54576 54584	line 107
T1503	Noun_Phrase 54590 54599	Figure 3B
T1504	IDENTITY_chain 54590 54599	Figure 3B
T1505	Noun_Phrase 54607 54640	Serial dilution filter trap assay
T1506	IDENTITY_chain 54607 54640	Serial dilution filter trap assay
T1507	Noun_Phrase 54623 54634	filter trap
T1508	Noun_Phrase 54679 54699	cortical homogenates
T1509	Noun_Phrase 54762 54794	the dilution series shown in (C)
T1510	Noun_Phrase 54816 54823	amyloid
T1511	Noun_Phrase 54843 54852	Figure S5
T1512	Noun_Phrase 54854 54873	aggregate formation
T1513	IDENTITY_chain 54854 54873	aggregate formation
T1514	Noun_Phrase 54931 54945	untreated mice
T1515	Noun_Phrase 55008 55027	Aggregate formation
T1516	Noun_Phrase 55055 55064	transgene
T1517	Noun_Phrase 55055 55076	transgene suppression
T1518	Noun_Phrase 55098 55137	9-mo-old mice treated with dox for 3 mo
T1519	Noun_Phrase 55177 55186	treatment
T1520	Noun_Phrase 55275 55298	9-mo-old untreated mice
T1521	Noun_Phrase 55363 55367	data
T1522	Noun_Phrase 55375 55384	Figure S6
T1523	Noun_Phrase 55396 55403	Amyloid
T1524	Noun_Phrase 55427 55436	Transgene
T1525	Noun_Phrase 55452 55476	Line 18 Tet-Off APP Mice
T1526	Noun_Phrase 55478 55485	Amyloid
T1527	Noun_Phrase 55586 55608	untreated tTA/APP mice
T1528	Noun_Phrase 55615 55676	a dramatic progression of pathology between 6 and 9 mo of age
T1529	IDENTITY_chain 55615 55676	a dramatic progression of pathology between 6 and 9 mo of age
T1530	Noun_Phrase 55693 55707	transgenic APP
T1531	Noun_Phrase 55693 55718	transgenic APP expression
T1532	Noun_Phrase 55727 55743	this progression
T1533	Noun_Phrase 55792 55807	6 mo + 3 mo dox
T1534	Noun_Phrase 55804 55807	dox
T1535	Noun_Phrase 55810 55816	Hirano
T1536	Noun_Phrase 55810 55829	Hirano silver stain
T1537	Noun_Phrase 55844 55856	thioflavin-S
T1538	Noun_Phrase 55916 55920	data
T1539	Noun_Phrase 55957 55988	Patients with Alzheimer disease
T1540	Noun_Phrase 55971 55988	Alzheimer disease
T1541	APPOS_relation 55971 55988	Alzheimer disease
T1542	Noun_Phrase 55990 55992	AD
T1543	Noun_Phrase 56018 56137	a small protein called amyloid-? peptide that sticks together to form what are known as amyloid plaques in their brains
T1544	Noun_Phrase 56106 56113	amyloid
T1545	Noun_Phrase 56125 56130	their
T1546	Noun_Phrase 56139 56151	This peptide
T1547	Noun_Phrase 56224 56273	a larger protein called amyloid precursor protein
T1548	Noun_Phrase 56275 56278	APP
T1549	APPOS_relation 56275 56278	APP
T1550	Noun_Phrase 56390 56393	APP
T1551	Nonreferential_pronoun 56404 56406	it
T1552	Noun_Phrase 56437 56457	the production of A?
T1553	Noun_Phrase 56455 56457	A?
T1554	Noun_Phrase 56506 56525	the amyloid plaques
T1555	Noun_Phrase 56510 56517	amyloid
T1556	Noun_Phrase 56590 56607	A?-lowering drugs
T1557	IDENTITY_chain 56590 56607	A?-lowering drugs
T1558	Noun_Phrase 56664 56668	they
T1559	Noun_Phrase 56709 56711	AD
T1560	Noun_Phrase 56723 56738	the Researchers
T1561	IDENTITY_chain 56723 56738	the Researchers
T1562	Noun_Phrase 56761 56798	new drugs designed to lower A? levels
T1563	IDENTITY_chain 56761 56798	new drugs designed to lower A? levels
T1564	Noun_Phrase 56789 56791	A?
T1565	Noun_Phrase 56789 56798	A? levels
T1566	Noun_Phrase 56825 56829	they
T1567	Noun_Phrase 56880 56891	the disease
T1568	Noun_Phrase 56945 56967	this type of treatment
T1569	Noun_Phrase 57014 57023	the drugs
T1570	Noun_Phrase 57062 57163	mice that produce too much APP and that develop the same amyloid lesions as do human patients with AD
T1571	IDENTITY_chain 57062 57163	mice that produce too much APP and that develop the same amyloid lesions as do human patients with AD
T1572	Noun_Phrase 57119 57126	amyloid
T1573	Noun_Phrase 57141 57163	human patients with AD
T1574	Noun_Phrase 57161 57163	AD
T1575	Noun_Phrase 57185 57195	these mice
T1576	Noun_Phrase 57238 57253	the researchers
T1577	Noun_Phrase 57266 57269	APP
T1578	Noun_Phrase 57281 57289	the mice
T1579	Noun_Phrase 57323 57333	these mice
T1580	Noun_Phrase 57366 57370	them
T1581	Noun_Phrase 57376 57393	A?-lowering drugs
T1582	Noun_Phrase 57402 57417	the researchers
T1583	Noun_Phrase 57456 57463	amyloid
T1584	Noun_Phrase 57478 57480	A?
T1585	Noun_Phrase 57478 57491	A? production
T1586	Noun_Phrase 57507 57511	They
T1587	Noun_Phrase 57533 57535	A?
T1588	Noun_Phrase 57533 57546	A? production
T1589	Noun_Phrase 57556 57575	the amyloid lesions
T1590	Noun_Phrase 57560 57567	amyloid
T1591	Noun_Phrase 57598 57609	the disease
T1592	Noun_Phrase 57638 57670	treatment with A?-lowering drugs
T1593	IDENTITY_chain 57638 57670	treatment with A?-lowering drugs
T1594	Noun_Phrase 57653 57670	A?-lowering drugs
T1595	Noun_Phrase 57691 57702	the disease
T1596	Noun_Phrase 57716 57725	the brain
T1597	Noun_Phrase 57731 57738	plaques
T1598	Noun_Phrase 57749 57764	the researchers
T1599	Noun_Phrase 57785 57792	amyloid
T1600	Noun_Phrase 57824 57833	treatment
T1601	Noun_Phrase 57873 57887	the experiment
T1602	Noun_Phrase 57920 57933	These results
T1603	Noun_Phrase 57948 57997	treatments designed to lower the production of A?
T1604	IDENTITY_chain 57948 57997	treatments designed to lower the production of A?
T1605	Noun_Phrase 57977 57997	the production of A?
T1606	Noun_Phrase 57995 57997	A?
T1607	Noun_Phrase 58033 58035	AD
T1608	Noun_Phrase 58050 58063	this approach
T1609	Noun_Phrase 58093 58100	amyloid
T1610	Noun_Phrase 58125 58140	the mouse brain
T1611	Noun_Phrase 58129 58134	mouse
T1612	Noun_Phrase 58154 58160	itself
T1613	Noun_Phrase 58162 58175	this strategy
T1614	Noun_Phrase 58199 58208	the brain
T1615	Noun_Phrase 58265 58274	treatment
T1616	Noun_Phrase 58350 58363	this approach
T1617	Noun_Phrase 58471 58488	Alzheimer disease
T1618	Noun_Phrase 58642 58659	Alzheimer disease
T1619	Noun_Phrase 58690 58717	The Alzheimer's Association
T1620	IDENTITY_chain 58690 58717	The Alzheimer's Association
T1621	Noun_Phrase 58820 58822	We
T1622	Noun_Phrase 58976 58994	Jackson Laboratory
T1623	Noun_Phrase 58996 58998	We
T1624	Noun_Phrase 59126 59136	Neil Segil
T1625	IDENTITY_chain 59126 59136	Neil Segil
T1626	Noun_Phrase 59160 59163	his
T1627	Noun_Phrase 59253 59259	animal
T1628	Noun_Phrase 59355 59357	We
T1629	Noun_Phrase 59381 59407	Takeda Chemical Industries
T1630	Noun_Phrase 59456 59495	Konrad Beyreuther and Andreas Weidemann
T1631	Noun_Phrase 59510 59524	22C11 antibody
T1632	Noun_Phrase 59530 59536	Ed Koo
T1633	Noun_Phrase 59549 59562	CT15 antibody
T1634	Noun_Phrase 59564 59573	This work
T1635	IDENTITY_chain 59564 59573	This work
T1636	Noun_Phrase 59658 59661	JLJ
T1637	Noun_Phrase 59758 59761	JLJ
T1638	Noun_Phrase 59792 59795	JLJ
T1639	Noun_Phrase 59798 59825	the Alzheimer's Association
T1640	Noun_Phrase 59841 59844	DRB
T1641	IDENTITY_chain 59841 59844	DRB
T1642	Noun_Phrase 59897 59900	JLJ
T1643	Noun_Phrase 59919 59922	DRB
T1644	Noun_Phrase 59942 59945	SGY
T1645	IDENTITY_chain 59942 59945	SGY
T1646	Noun_Phrase 59966 59969	SGY
T1647	Noun_Phrase 60044 60047	DRB
T1648	Noun_Phrase 60164 60170	animal
T1649	Noun_Phrase 60212 60221	this work
T1650	Noun_Phrase 60251 60255	data
T1651	Noun_Phrase 60352 60354	A?
T1652	APPOS_relation 60352 60354	A?
T1653	Noun_Phrase 60357 60366	amyloid-?
T1654	Noun_Phrase 60368 60370	AD
T1655	APPOS_relation 60368 60370	AD
T1656	Noun_Phrase 60373 60390	Alzheimer disease
T1657	Noun_Phrase 60392 60396	APLP
T1658	APPOS_relation 60392 60396	APLP
T1659	Noun_Phrase 60399 60429	amyloid precursor–like protein
T1660	Noun_Phrase 60431 60434	APP
T1661	APPOS_relation 60431 60434	APP
T1662	Noun_Phrase 60437 60462	amyloid precursor protein
T1663	Noun_Phrase 60464 60471	CaMKII?
T1664	APPOS_relation 60464 60471	CaMKII?
T1665	Noun_Phrase 60474 60503	calcium-calmodulin kinase II?
T1666	Noun_Phrase 60505 60508	dox
T1667	Noun_Phrase 60511 60522	doxycycline
T1668	APPOS_relation 60511 60522	doxycycline
T1669	Noun_Phrase 60524 60526	FA
T1670	APPOS_relation 60524 60526	FA
T1671	Noun_Phrase 60529 60540	formic acid
T1672	Noun_Phrase 60542 60546	GFAP
T1673	APPOS_relation 60542 60546	GFAP
T1674	Noun_Phrase 60549 60580	glial fibrillary acidic protein
T1675	Noun_Phrase 60582 60593	mo/huAPP695
T1676	APPOS_relation 60582 60593	mo/huAPP695
T1677	Noun_Phrase 60596 60632	mouse APP with a humanized A? domain
T1678	Noun_Phrase 60634 60637	PBS
T1679	APPOS_relation 60634 60637	PBS
T1680	Noun_Phrase 60640 60665	phosphate-buffered saline
T1681	Noun_Phrase 60667 60670	SDS
T1682	APPOS_relation 60667 60670	SDS
T1683	Noun_Phrase 60673 60695	sodium dodecyl sulfate
T1684	Noun_Phrase 60697 60704	swe/ind
T1685	APPOS_relation 60697 60704	swe/ind
T1686	Noun_Phrase 60707 60722	Swedish/Indiana
T1687	Noun_Phrase 60724 60727	tTA
T1688	APPOS_relation 60724 60727	tTA
T1689	Noun_Phrase 60730 60757	tetracycline transactivator
T1690	Noun_Phrase 60779 60787	Figure 1
T1691	Noun_Phrase 60779 60787;60835 60836	Figure 1 A
T1692	Noun_Phrase 60779 60787;61360 61361	Figure 1 B
T1693	IDENTITY_chain 60779 60787;61360 61361	Figure 1 B
T1694	Noun_Phrase 60779 60787;61545 61546	Figure 1 C
T1695	Noun_Phrase 60779 60787;61606 61607	Figure 1 A
T1696	Noun_Phrase 60779 60787;61991 61992	Figure 1 D
T1697	Noun_Phrase 60779 60787;62052 62053	Figure 1 B
T1698	Noun_Phrase 60800 60814	Transgenic APP
T1699	Noun_Phrase 60800 60825	Transgenic APP Expression
T1700	Noun_Phrase 60829 60832	Dox
T1701	Noun_Phrase 60838 60912	Western blotting for transgenic APP using the human-specific 6E10 antibody
T1702	IDENTITY_chain 60838 60912	Western blotting for transgenic APP using the human-specific 6E10 antibody
T1703	Noun_Phrase 60859 60873	transgenic APP
T1704	Noun_Phrase 60880 60912	the human-specific 6E10 antibody
T1705	Noun_Phrase 60933 61020	full-length protein in forebrain tissue from young predeposit double transgenic animals
T1706	IDENTITY_chain 60933 61020	full-length protein in forebrain tissue from young predeposit double transgenic animals
T1707	Noun_Phrase 60956 60965	forebrain
T1708	Noun_Phrase 60978 61020	young predeposit double transgenic animals
T1709	IDENTITY_chain 60978 61020	young predeposit double transgenic animals
T1710	Noun_Phrase 61022 61030	line 107
T1711	Noun_Phrase 61036 61039	its
T1712	Noun_Phrase 61062 61065	dox
T1713	Noun_Phrase 61062 61075	dox treatment
T1714	Noun_Phrase 61077 61094	Untreated animals
T1715	Noun_Phrase 61115 61124	transgene
T1716	Noun_Phrase 61115 61135	transgene expression
T1717	Noun_Phrase 61137 61144	protein
T1718	Noun_Phrase 61173 61214	animals acutely treated with dox for 2 wk
T1719	Noun_Phrase 61279 61302	acutely treated animals
T1720	Noun_Phrase 61329 61356	mice born and raised on dox
T1721	Noun_Phrase 61353 61356	dox
T1722	Noun_Phrase 61363 61461	Immunoblotting with the N-terminal antibody 22C11 to detect both transgenic and endogenous protein
T1723	IDENTITY_chain 61363 61461	Immunoblotting with the N-terminal antibody 22C11 to detect both transgenic and endogenous protein
T1724	Noun_Phrase 61383 61412	the N-terminal antibody 22C11
T1725	Noun_Phrase 61473 61476	dox
T1726	Noun_Phrase 61473 61486	dox treatment
T1727	Noun_Phrase 61523 61541	nontransgenic mice
T1728	Noun_Phrase 61585 61608	the Western blot in (A)
T1729	Noun_Phrase 61615 61629	transgenic APP
T1730	Noun_Phrase 61615 61636	transgenic APP levels
T1731	IDENTITY_chain 61615 61636	transgenic APP levels
T1732	Noun_Phrase 61668 61671	dox
T1733	Noun_Phrase 61680 61687;61704 61719	acutely treated animals
T1734	Noun_Phrase 61692 61719	chronically treated animals
T1735	Noun_Phrase 61731 61746	4 wk + 2 wk dox
T1736	Noun_Phrase 61758 61771	reared on dox
T1737	Noun_Phrase 61768 61771	dox
T1738	Noun_Phrase 61779 61793	4 wk untreated
T1739	Noun_Phrase 61854 61857	APP
T1740	Noun_Phrase 61868 61883	4 wk + 2 wk dox
T1741	Noun_Phrase 61885 61898	reared on dox
T1742	Noun_Phrase 61895 61898	dox
T1743	Noun_Phrase 61904 61917	nontransgenic
T1744	APPOS_relation 61904 61917	nontransgenic
T1745	Noun_Phrase 61919 61922	NTg
T1746	Noun_Phrase 62031 62054	the Western blot in (B)
T1747	Noun_Phrase 62086 62110	dox-treated tTA/APP mice
T1748	Noun_Phrase 62143 62166	4-wk-old untreated mice
T1749	Noun_Phrase 62262 62283	nontransgenic animals
T1750	Noun_Phrase 62336 62359	untreated 4-wk-old mice
T1751	Noun_Phrase 62428 62436;62816 62817	Figure 2 A
T1752	Noun_Phrase 62428 62436;63131 63132	Figure 2 B
T1753	Noun_Phrase 62428 62436;63854 63855	Figure 2 C
T1754	Noun_Phrase 62428 62436;64442 64443	Figure 2 D
T1755	Noun_Phrase 62438 62440	A?
T1756	Noun_Phrase 62438 62447	A? Levels
T1757	Noun_Phrase 62476 62485	Transgene
T1758	Noun_Phrase 62476 62497	Transgene Suppression
T1759	Noun_Phrase 62525 62589	young, predeposit tTA/APP mice used for Western blot in Figure 1
T1760	Noun_Phrase 62591 62599	line 107
T1761	Noun_Phrase 62775 62779	A?40
T1762	Noun_Phrase 62799 62803	A?42
T1763	Noun_Phrase 62819 62833	PBS-soluble A?
T1764	Noun_Phrase 62875 62880;62893 62906	acute dox treatment
T1765	Noun_Phrase 62885 62906	chronic dox treatment
T1766	Noun_Phrase 62893 62896	dox
T1767	Noun_Phrase 62983 62987	A?40
T1768	Noun_Phrase 62983 62996	A?40 and A?42
T1769	Noun_Phrase 62992 62996	A?42
T1770	Noun_Phrase 63013 63015	A?
T1771	Noun_Phrase 63026 63041	treated animals
T1772	Noun_Phrase 63069 63082	nontransgenic
T1773	Noun_Phrase 63069 63096	nontransgenic (NTg) animals
T1774	Noun_Phrase 63084 63087	NTg
T1775	Noun_Phrase 63137 63217	the young animals tested here prior to the formation of visible amyloid deposits
T1776	Noun_Phrase 63201 63208	amyloid
T1777	Noun_Phrase 63245 63261	the SDS fraction
T1778	Noun_Phrase 63336 63360	the PBS-soluble fraction
T1779	Noun_Phrase 63362 63364	A?
T1780	Noun_Phrase 63375 63391	the SDS fraction
T1781	Noun_Phrase 63421 63424	dox
T1782	Noun_Phrase 63421 63434	dox treatment
T1783	Noun_Phrase 63447 63464	untreated animals
T1784	Noun_Phrase 63530 63534	A?40
T1785	Noun_Phrase 63530 63543	A?40 and A?42
T1786	Noun_Phrase 63539 63543	A?42
T1787	Noun_Phrase 63560 63583	Acutely treated animals
T1788	Noun_Phrase 63674 63687	nontransgeinc
T1789	Noun_Phrase 63719 63721	A?
T1790	Noun_Phrase 63732 63759	mice born and raised on dox
T1791	Noun_Phrase 63756 63759	dox
T1792	Noun_Phrase 63806 63819	nontransgenic
T1793	Noun_Phrase 63857 63880	The FA-soluble fraction
T1794	Noun_Phrase 63999 64012	nontransgenic
T1795	Noun_Phrase 64142 64157	the FA fraction
T1796	Noun_Phrase 64298 64317	acute dox treatment
T1797	Noun_Phrase 64304 64307	dox
T1798	Noun_Phrase 64417 64430	aggregated A?
T1799	Noun_Phrase 64461 64469	total A?
T1800	Noun_Phrase 64481 64527	both endogenous and transgene-derived peptides
T1801	IDENTITY_chain 64481 64527	both endogenous and transgene-derived peptides
T1802	Noun_Phrase 64539 64569	animals born and raised on dox
T1803	Noun_Phrase 64566 64569	dox
T1804	Noun_Phrase 64577 64579	A?
T1805	Noun_Phrase 64600 64621	nontransgenic animals
T1806	Noun_Phrase 64715 64719	A?40
T1807	Noun_Phrase 64715 64728	A?40 and A?42
T1808	Noun_Phrase 64724 64728	A?42
T1809	Noun_Phrase 64761 64770	transgene
T1810	Noun_Phrase 64811 64824	both peptides
T1811	Noun_Phrase 64826 64845	acute dox treatment
T1812	Noun_Phrase 64832 64835	dox
T1813	Noun_Phrase 64863 64867	A?40
T1814	Noun_Phrase 64986 65015	acutely treated young animals
T1815	Noun_Phrase 65063 65066;65075 65087	the FA fractions
T1816	Noun_Phrase 65063 65070;65078 65087	the SDS fractions
T1817	Noun_Phrase 65139 65162	4-wk-old untreated mice
T1818	Noun_Phrase 65226 65234;65316 65317	Figure 3 A
T1819	IDENTITY_chain 65226 65234;65316 65317	Figure 3 A
T1820	Noun_Phrase 65226 65234;65650 65651	Figure 3 B
T1821	Noun_Phrase 65226 65234;65718 65719	Figure 3 A
T1822	Noun_Phrase 65226 65234;66428 66429	Figure 3 D
T1823	Noun_Phrase 65243 65252	Transgene
T1824	Noun_Phrase 65296 65303	Amyloid
T1825	Noun_Phrase 65413 65421	line 107
T1826	Noun_Phrase 65447 65475	human-specific antibody 6E10
T1827	Noun_Phrase 65487 65496	transgene
T1828	Noun_Phrase 65519 65545	3 or 6 mo of dox treatment
T1829	IDENTITY_chain 65519 65545	3 or 6 mo of dox treatment
T1830	Noun_Phrase 65532 65535	dox
T1831	Noun_Phrase 65532 65545	dox treatment
T1832	Noun_Phrase 65547 65555	The blot
T1833	IDENTITY_chain 65547 65555	The blot
T1834	Noun_Phrase 65581 65614	endogenous superoxide dismutase 1
T1835	Noun_Phrase 65592 65614	superoxide dismutase 1
T1836	APPOS_relation 65592 65614	superoxide dismutase 1
T1837	Noun_Phrase 65616 65620	SOD1
T1838	Noun_Phrase 65691 65720	the Western blot shown in (A)
T1839	Noun_Phrase 65722 65736	Transgenic APP
T1840	Noun_Phrase 65722 65743	Transgenic APP levels
T1841	Noun_Phrase 65783 65809	3 or 6 mo of dox treatment
T1842	Noun_Phrase 65796 65799	dox
T1843	Noun_Phrase 65796 65809	dox treatment
T1844	Noun_Phrase 65868 65894	6-mo-old untreated animals
T1845	Noun_Phrase 66023 66032	transgene
T1846	Noun_Phrase 66092 66099	amyloid
T1847	Noun_Phrase 66092 66109	amyloid pathology
T1848	Noun_Phrase 66115 66123	Figure 1
T1849	Noun_Phrase 66213 66215	A?
T1850	Noun_Phrase 66231 66238	amyloid
T1851	Noun_Phrase 66280 66282	we
T1852	Noun_Phrase 66292 66341	untreated controls harvested at 6 and 9 mo of age
T1853	Noun_Phrase 66345 66424	animals placed on dox at 6 mo of age and harvested after 3 or 6 mo of treatment
T1854	Noun_Phrase 66363 66366	dox
T1855	Noun_Phrase 66402 66424	3 or 6 mo of treatment
T1856	Noun_Phrase 66415 66424	treatment
T1857	Noun_Phrase 66431 66434	Dox
T1858	Noun_Phrase 66431 66444	Dox treatment
T1859	Noun_Phrase 66460 66469	transgene
T1860	Noun_Phrase 66490 66511	6-mo-old tTA/APP mice
T1861	Noun_Phrase 66533 66537	6E10
T1862	Noun_Phrase 66544 66554	APPswe/ind
T1863	Noun_Phrase 66626 66629	dox
T1864	Noun_Phrase 66713 66726	CT15 antibody
T1865	Noun_Phrase 66758 66760	A?
T1866	Noun_Phrase 66856 66878	superoxide dismutase 1
T1867	Noun_Phrase 66963 66967	6E10
T1868	Noun_Phrase 66976 66984	Figure 4
T1869	Noun_Phrase 66976 66984;67059 67060	Figure 4 A
T1870	Noun_Phrase 66976 66984;67363 67364	Figure 4 B
T1871	Noun_Phrase 66976 66984;67466 67467	Figure 4 A
T1872	Noun_Phrase 67001 67015	Transgenic APP
T1873	Noun_Phrase 67039 67046	Amyloid
T1874	Noun_Phrase 67039 67056	Amyloid Pathology
T1875	Noun_Phrase 67062 67075	Aggregated A?
T1876	Noun_Phrase 67115 67126;67147 67151	dox-treated mice
T1877	Noun_Phrase 67131 67151	control tTA/APP mice
T1878	Noun_Phrase 67153 67161	line 107
T1879	Noun_Phrase 67171 67182	filter trap
T1880	Noun_Phrase 67190 67228	Serial dilutions of protein homogenate
T1881	Noun_Phrase 67210 67217	protein
T1882	Noun_Phrase 67210 67228	protein homogenate
T1883	Noun_Phrase 67277 67284	protein
T1884	Noun_Phrase 67357 67359	A?
T1885	Noun_Phrase 67427 67438	filter trap
T1886	Noun_Phrase 67530 67543	Aggregated A?
T1887	Noun_Phrase 67597 67611	untreated mice
T1888	Noun_Phrase 67731 67740	transgene
T1889	Noun_Phrase 67731 67752	transgene suppression
T1890	Noun_Phrase 67768 67781	aggregated A?
T1891	Noun_Phrase 67799 67828	untreated mice at 6 mo of age
T1892	Noun_Phrase 67840 67880	9- or 12-mo-old animals treated with dox
T1893	Noun_Phrase 67877 67880	dox
T1894	Noun_Phrase 68051 68074	9-mo-old untreated mice
T1895	Noun_Phrase 68119 68142	9-mo-old untreated mice
T1896	Noun_Phrase 68167 68174	Amyloid
T1897	Noun_Phrase 68254 68260	Hirano
T1898	Noun_Phrase 68254 68273	Hirano silver stain
T1899	Noun_Phrase 68285 68297	thioflavin-S
T1900	Noun_Phrase 68316 68318	A?
T1901	Noun_Phrase 68316 68339	A? immunohistochemistry
T1902	Noun_Phrase 68354 68361	Amyloid
T1903	Noun_Phrase 68354 68368	Amyloid burden
T1904	Noun_Phrase 68421 68438	untreated animals
T1905	Noun_Phrase 68510 68525	6 mo + 3 mo dox
T1906	Noun_Phrase 68530 68545	6 mo + 6 mo dox
T1907	Noun_Phrase 68612 68619	amyloid
T1908	Noun_Phrase 68650 68658	Figure 5
T1909	Noun_Phrase 68650 68658;69239 69240	Figure 5 A
T1910	Noun_Phrase 68650 68658;69245 69246	Figure 5 B
T1911	Noun_Phrase 68650 68658;70000 70001	Figure 5 C
T1912	Noun_Phrase 68650 68658;70091 70092	Figure 5 A
T1913	Noun_Phrase 68650 68658;70099 70100	Figure 5 B
T1914	Noun_Phrase 68660 68662	A?
T1915	Noun_Phrase 68660 68668	A? ELISA
T1916	Noun_Phrase 68766 68768	A?
T1917	Noun_Phrase 68779 68826	untreated 6- and 9-mo-old tTA/APP line 107 mice
T1918	Noun_Phrase 68837 68845	Figure 4
T1919	Noun_Phrase 68873 68935	9- and 12-mo-old animals treated with dox from the age of 6 mo
T1920	Noun_Phrase 68911 68914	dox
T1921	Noun_Phrase 68944 68958	transgenic APP
T1922	Noun_Phrase 69003 69023	Cortical homogenates
T1923	Noun_Phrase 69083 69106	PBS, 2% SDS, and 70% FA
T1924	Noun_Phrase 69198 69202	A?40
T1925	Noun_Phrase 69222 69226	A?42
T1926	Noun_Phrase 69311 69314;69322 69335	the SDS fractions
T1927	Noun_Phrase 69311 69317;69326 69335	the FA fractions
T1928	Noun_Phrase 69353 69360	amyloid
T1929	Noun_Phrase 69353 69367	amyloid burden
T1930	Noun_Phrase 69369 69378	Figures 4
T1931	Noun_Phrase 69383 69392	Figure S3
T1932	Noun_Phrase 69430 69453	untreated 9-mo-old mice
T1933	Noun_Phrase 69488 69511	untreated 6-mo-old mice
T1934	Noun_Phrase 69582 69585;69593 69602	SDS fractions
T1935	Noun_Phrase 69590 69602	FA fractions
T1936	Noun_Phrase 69660 69669	transgene
T1937	Noun_Phrase 69660 69681	transgene suppression
T1938	Noun_Phrase 69687 69689	A?
T1939	Noun_Phrase 69777 69796	6 mo untreated mice
T1940	Noun_Phrase 69870 69893	9-mo-old untreated mice
T1941	Noun_Phrase 69944 69967	9-mo-old untreated mice
T1942	Noun_Phrase 70003 70019	The PBS fraction
T1943	Noun_Phrase 70049 70057	total A?
T1944	Noun_Phrase 70121 70123	A?
T1945	Noun_Phrase 70134 70154	the dox-treated mice
T1946	Noun_Phrase 70176 70198	younger untreated mice
T1947	Noun_Phrase 70209 70222	both peptides
T1948	Noun_Phrase 70242 70260	the treated groups
T1949	Noun_Phrase 70273 70300	the untreated 6-mo-old mice
T1950	Noun_Phrase 70307 70311	A?40
T1951	Noun_Phrase 70484 70488	A?42
T1952	Noun_Phrase 70544 70560	PBS-soluble A?42
T1953	Noun_Phrase 70636 70649;70657 70672	the untreated 9-mo-old groups
T1954	Noun_Phrase 70636 70652;70659 70672	the untreated 6- mo-old groups
T1955	Noun_Phrase 70693 70716	6-mo-old untreated mice
T1956	Noun_Phrase 70761 70784	6-mo-old untreated mice
T1957	Noun_Phrase 70805 70813	Figure 6
T1958	Noun_Phrase 70815 70843	Neuritic and Glial Pathology
T1959	Noun_Phrase 70868 70877	Transgene
T1960	Noun_Phrase 70868 70889	Transgene Suppression
T1961	Noun_Phrase 70969 70985	tet-off APP mice
T1962	Noun_Phrase 70987 70995	line 107
T1963	Noun_Phrase 71148 71162	untreated mice
T1964	Noun_Phrase 71239 71248	transgene
T1965	Noun_Phrase 71239 71260	transgene suppression
T1966	Noun_Phrase 71262 71268	Hirano
T1967	Noun_Phrase 71262 71281	Hirano silver stain
T1968	Noun_Phrase 71293 71297	GFAP
T1969	Noun_Phrase 71333 71342	ubiquitin
T1970	Noun_Phrase 71379 71387	Figure 7
T1971	Noun_Phrase 71379 71387;71454 71455	Figure 7 A
T1972	IDENTITY_chain 71379 71387;71454 71455	Figure 7 A
T1973	Noun_Phrase 71379 71387;71709 71710	Figure 7 B
T1974	IDENTITY_chain 71379 71387;71709 71710	Figure 7 B
T1975	Noun_Phrase 71379 71387;71736 71737	Figure 7 A
T1976	Noun_Phrase 71379 71387;71818 71819	Figure 7 C
T1977	Noun_Phrase 71379 71387;71878 71879	Figure 7 A
T1978	Noun_Phrase 71379 71387;71886 71887	Figure 7 B
T1979	Noun_Phrase 71379 71387;72113 72114	Figure 7 A
T1980	Noun_Phrase 71389 71398	Transgene
T1981	Noun_Phrase 71389 71410	Transgene Suppression
T1982	Noun_Phrase 71422 71451	Hyperactivity in tTA/APP Mice
T1983	Noun_Phrase 71439 71451	tTA/APP Mice
T1984	Noun_Phrase 71439 71451	tTA/APP Mice
T1985	Noun_Phrase 71494 71551	extreme hyperactivity in untreated double transgenic mice
T1986	Noun_Phrase 71519 71551	untreated double transgenic mice
T1987	Noun_Phrase 71564 71581;71600 71608	single transgenic controls
T1988	Noun_Phrase 71586 71608	nontransgenic controls
T1989	Noun_Phrase 71610 71618	line 107
T1990	Noun_Phrase 71672 71698	the double transgenic mice
T1991	Noun_Phrase 71702 71705	dox
T1992	Noun_Phrase 71774 71791;71808 71814	untreated control groups
T1993	Noun_Phrase 71796 71814	dox-treated groups
T1994	Noun_Phrase 71929 71932;71954 71982	the nontransgenic control groups
T1995	Noun_Phrase 71929 71950;71968 71982	the single transgenic control groups
T1996	Noun_Phrase 71991 72045	the hyperactivity present in untreated tTA/APP animals
T1997	Noun_Phrase 72020 72045	untreated tTA/APP animals
